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Nuclear lamins and nuclear pore complexes (NPCs) are major components of the nuclear
envelope in metazoan cells. The objectives of this thesis were first to study interactions
between nuclear lamins and the nuclear pore protein Nup153 (Chapters 2 and 3) and sec-
ond to determine lamin assembly conditions of the Xenopus oocytes LIII in vitro (Chapter
4). Nuclear lamins are major constituents of the nuclear lamina underlying the nuclear pe-
riphery along with inner nuclear membrane proteins. The nuclear lamina provides stability
and determines the nuclear architecture and spacing of the NPCs. NPCs form supramolec-
ular assemblies that regulate nucleocytoplasmic transport. An overview of the functional
aspects associated with the nuclear lamina and NPCs in health and disease is provided
in Chapter 1. In depth analysis of the interaction of nuclear lamins with the nucleoporin
Nup153 is revealed in Chapters 2 and 3. Using in vitro solution binding assays as well
as immunoprecipitation assays, in chapter 2 we show direct associations between Nup153
and nuclear lamins. This work is explored even further in chapter 3 using binding assays
and immunofluorescence microscopy as well as immunoprecipitation assays; we examined
the interaction in the presence of lamin related mutations. Finally, in chapter 4 we estab-
lished buffer conditions for LIII assembly in vitro, analysed by electron microscopy (EM)
using glycerol spraying/low-angle rotary metal shadowing and negative staining. Our
results presented in this thesis contribute to expand our current knowledge of the interac-
tions of the NPCs with the nuclear lamins, as well as to increase our understanding of the
impact of mutations in lamins that can cause laminopathies. In addition, the studies on the
assembly conditions of LIII provide a vehicle for further characterisation of the influence
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1The nuclear lamina and the nuclear
pore complex - implications in
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Teiba Al-Haboubi and Birthe Fahrenkrog





The nuclear envelope (NE) of eukaryotic cells represents a physical barrier separating the
nucleus from the cytoplasm. It is comprised of an outer (ONM) and an inner (INM) nuclear
membrane, separated by a perinuclear space (PNS). The ONM is continuous with the endo-
plasmic reticulum (ER), linking the PNS to the ER lumen. The INM represents a site where
the nuclear lamina and chromatin are anchored to the nuclear periphery by interacting
with several integral membrane proteins. The ONM and the INM fuse at sites of the nu-
clear pore complexes (NPCs). Some of the functions assigned for the NE include chromatin
organisation, transcriptional regulation, mechanical integrity and signalling pathways, as
well as acting as a key component in the organisation and function of the cytoskeleton.
At the nuclear face, the NPCs are in close proximity to the nuclear lamina and their incor-
poration into the NE and spacing depend on the nuclear lamina by means of interactions
between distinct nucleoporins and the nuclear lamins. Defects in proteins of the NE, the
nuclear lamina and the NPCs cause several inherited diseases and abnormalities. Here, we
summarise the current state of knowledge of the interactions between the NPC with the
nuclear lamins and other associated nuclear proteins and their influence in viral infections
and disease.
1.2 Introduction
The nuclear envelope (NE) does not merely isolate the chromosomes from the cytoplasm,
but recently has been shown to play multiple roles in cell division, and to provide a linker
site to the cytoplasm (Gerace and Burke, 1988; Starr, 2009). The outer nuclear membrane
(ONM) is continuous with the endoplasmic reticulum (ER) and contains distinct group
of proteins that share a common protein domain first found in Drosophila melanogaster
ONM protein, termed the KASH domain (Klarsicht, Anc-1, Syne Homology) as well as
in Caenorhabditis elegans, and human, respectively (Figure 1.1) (Stewart-Hutchinson et
al., 2008). Moreover, in mammalian cell nesprins (NE spectrin repeat proteins) consti-
tute a large family of ONM proteins that contain a KASH domain at the C-terminus for
their localisation to the ONM and multiple spectrin-repeats extending to the cytoplasm
(Zhang et al., 2002; Zhang et al., 2001). Nesprins associate with cytoskeleton components
such as actin and plectin and are involved in nuclear positioning and migration (Zhen et
2
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al., 2002). In addition, nesprins interact with SUN domain (Sad1p, Unc-84) containing
proteins, first found in C.elegans these are the mammalian homologue of the C-terminal
domain of Sad1p, a spindle pole body protein in Schizosaccharomyces pombe (Hodzic et al.,
2004). Unc-84 is localised at the inner nuclear membrane (INM) and has a SUN-domain
that anchors the ONM protein Anc-1 (Starr and Han, 2003). In mammalian cells, SUN1
and SUN2 are required for tethering the ONM proteins nesprin 1 giant and 2, respectively
(Haque et al., 2006; Hodzic et al., 2004; Padmakumar et al., 2005). SUN domains are also
implicated in other nuclear related functions; SUN1 is clustered around the NPCs (Liu et
al., 2007) and telomeres in meiosis (Ding et al., 2007). In addition, SUN-domains inter-
act with A-type lamins (Haque et al., 2006). The nesprin-SUN interactions are involved
in LINC complexes (linker of nucleoskeleton and cytoskeleton) effectively connecting the
actin cytoskeleton and microtubules to the nuclear lamina and are also implicated in NE
organisation and spacing between the INM and the ONM (Crisp et al., 2006; Stewart-
Hutchinson et al., 2008). An interesting hypothesis is that the SUN/KASH system transfers
cytoskeletal information such as signs of mechanical stress, to the nucleus by means of
interactions with the nuclear lamina, and subsequently activating the appropriate cellular
responses. Several INM proteins associate with nuclear lamins such as lamin B receptor
(LBR), LAP2, MAN1, emerin as well as others (Schirmer and Foisner, 2007). LAP2, MAN1
and emerin share a common domain, termed LEM (LAP2, emerin, MAN1), whereby they
associate with lamin and chromatin (Lin et al., 2000; Liu et al., 2003a). The nuclear lamina
is a filamentous meshwork composed mainly of A-, and B-type lamins which assemble into
a 10 nm filamentous network in mammalian cells (Aebi et al., 1986), and are anchored to
the INM through interactions with proteins of the INM (Herrmann and Aebi, 2000; Stuur-
man et al., 1998). Residing between the ONM and INM are the nuclear pore complexes
(NPCs), large protein assemblies, comprising 30 different proteins termed nucleoporins
and involved mainly in nucleocytoplasmic transport (Rout and Wente, 1994). Both the
nuclear lamina and the NPCs are disassembled during NE breakdown, an essential process
that enables spindle microtubules that assemble in the cytoplasm to access mitotic chro-
matin, a process that involves a series of phosphorylation of NE related proteins (D’Angelo
and Hetzer, 2006). Components of the nuclear lamina as well as the NPCs are implicated in
mitotic spindle assembly and are recruited to chromatin during cell division (Nigg, 1992a;
Salina et al., 2001; Tsai et al., 2006). The nuclear lamina is implicated in the maintenance
of the nuclear architecture and mechanical stability of the nucleus (Dahl et al., 2008), and
3
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involved in multiple nuclear processes including chromatin organisation, DNA replication
and RNA transcription (Dechat et al., 2008b). In addition, it is involved in cellular differ-
entiation and spacing of the NPCs by means of interactions with individual nuclear pore
proteins (Maeshima et al., 2006). The distinct roles of the nuclear lamins and the NPCs in
nuclear related functions are reviewed in the following sections.
Figure 1.1: Structural organisation of the nuclear envelope - The nuclear envelope (NE)
of metazoan cells is defined by an outer (ONM) and an inner nuclear membrane (INM) sep-
arated by a perinuclear space (PNS), and by a nuclear lamina and nuclear pore complexes
(NPCs). Proteins of the INM interact both with the underlying nuclear lamina as well as with
chromatin. Such INM associated proteins include lamin B receptor (LBR) which interacts with
B-type lamins, and chromatin associated heterochromatin protein 1 (HP1). LEM domain con-
taining integral proteins (LAP2, emerin and MAN1) form complexes with A- and/or B-type
lamins. The INM SUN proteins interact with lamin A as well as nesprin proteins of the ONM
which inturn interact with actin and plectin as illustrated, linking the nucleoskeleton with the
cytoskeleton. Adapted from (Guttinger et al., 2009)
1.3 Nuclear lamins - domain organisation
Lamins are type V intermediate filament proteins (IFs). Like all IFs, lamins have a tripar-
tite domain organisation with a central α-helical coiled-coil rod domain flanked by two
non-helical short N-terminal (head) domain and a longer C-terminal (tail) domain (Figure
4
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1.2). The rod domain consists of four coiled coil segments 1A, 1B, 2A and 2B separated by
three linkers (Heins and Aebi, 1994). Within segment 1B of the rod domain an additional
42 amino acid residues are present which are shared only with IFs of invertebrates (Figure
1.2) (Herrmann and Aebi, 2004). The C-terminal domain has a nuclear localisation signal
(NLS), an immunoglobulin-like motif (Ig-fold) domain (Dhe-Paganon et al., 2002; Krimm
et al., 2002), and a -CAAX box domain that undergoes multiple posttranslational modifica-
tions (Ralle et al., 2004). Lamins have multiple phophorylation sites, which have several
roles in the assembly and disassembly of lamins from the lamina during NE breakdown at
the onset of mitosis (Heald and McKeon, 1990; Moir et al., 1995; Nigg, 1992a; Peter et al.,
1991).
Figure 1.2: Model of domain organisation of nuclear lamin compared to cytoplasmic
intermediate filament protein - Like all intermediate filament proteins (IFs), lamin structure
is organised in three domains, a central α-helical coiled-coil rod domain flanked by two non
helical N- and C-terminal domains. In comparison to the cytoplasmic IF vimentin, human
lamin A has a shorter N-terminal (head) domain. The rod domain has similar heptad repeat
segments designated 1A, 1B, 2A and 2B, separated by three linkers L1, L12 and L2. In addition
the rod domain of lamins contains an extra 42 residues at segment 1B. The tail domain of
lamins is larger and contains distinct structural features not shared with cytoplasmic IFs: a
nuclear localisation signal (NLS), an immunoglobulin like fold (Ig-fold), in the tail domain
(red, beta sheet structures) and a CAAX-box at the end of the tail domain (not shown, see
Figure 1.3). The numbers in brackets correspond to the amino acid numbers in each respective
domain. Adapted from (Herrmann et al., 2007)
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1.3.1 Lamin isoforms in vertebrates
Two types of lamins exist in the mammalian cell, A- and B-type lamins which differ in
their expression pattern, solubility properties and behaviour during mitosis (Schirmer and
Gerace, 2004). Expressed only in differentiated cells, A-type lamins are present in four iso-
forms which are all transcribed from the same gene, LMNA (Constantinescu et al., 2006).
Lamin A and C are the main isoforms expressed simultaneously in all differentiated somatic
cells and generally termed lamin A/C. Other minor isoforms can be found in cells of the
germ-line, lamin A∆10 and lamin C2, which are specific to spermatogenic cells (Alsheimer
and Benavente, 1996; Furukawa et al., 1994). A-type lamins are present at the nuclear
periphery as part of the nuclear lamina meshwork and as a soluble pool in the nucleoplasm
(Foisner, 2001; Goldman et al., 2002). B-type lamins are expressed in all cell types and are
found in two major isoforms lamin B1 and B2, which are encoded by two separate genes
LMNB1 and LMNB2, respectively (Lin and Worman, 1995; Vorburger et al., 1989). Other
minor isoforms of B-type lamins also exist, lamin B3 is a germ-line specific B-type lamin
and lamin B4, which is found in sperm cells (Benavente et al., 1985; Furukawa and Hotta,
1993). Nuclear lamins are mainly present in the nuclear lamina, however, a small pool is
also found in the nucleoplasm in an unknown structural form (Dorner et al., 2007). The
incorporation of lamins into the nuclear lamina requires in addition to the NLS other seg-
ments including the head domain, part of the 42 residues at segment 1B of the rod domain
as well as the CAAX-box domain at the C-terminus (Monteiro et al., 1994).
Lamins A, B1 and B2 undergo a series of posttranslational modifications at their C-
terminal CAAX-box domain (where C is a cysteine, followed by two aliphatic residues AA
and X can be any of several amino acid) (Mical and Monteiro, 1998). The sequence of
this domain is CSIM and CAIM for lamins A and B1, respectively, while lamin C does not
have this domain (Ralle et al., 2004). Three sequential modifications take place at the
CAAX-box domain starting with farnesylation of the CAAX-box cysteine residue by a farne-
syltransferase enzyme (see Figure 1.3), followed by endoproteolytic removal of the three
remaining residues -AAX by the endoprotease RCE1 in lamin B and ZMPSTE24 in lamin A,
respectively, and methylation on the new carboxyl-terminal cysteine by methyltransferase,
ICMT (Rusinol and Sinensky, 2006; Sobotka-Briner and Chelsky, 1992). Prelamin A un-
dergoes yet a second cleavage by ZMPSTE24 deleting 15 more residues at the C-terminus
including the newly farnesylated and carboxy-methylated cysteine (Sinensky et al., 1994;
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Young et al., 2005). Thus, while the mammalian B-type lamins are farnesylated proteins
and associate tightly to the INM, the mature A-type lamins are not farnesylated.
Recently, lamins have been shown to undergo other posttranslational modifications
such as sumoylation, where the inhibition of the latter by mutations in the lamin gene led
to lamin aggregation and cell death (Zhang and Sarge, 2008).
Figure 1.3: Post translational processing of nuclear lamins - Schematic representations of
lamin domain organisation and post translational modifications. (A) Lamin molecule showing
the tripartite domain organisation, note the -CAAX box in the end of the tail domain (green) is
found in B type lamins and lamin A, but not in lamin C. (B) Three sequential modifications take
place at the CAAX-box starting with farnesylation of the CAAX-box cysteine residue by a farne-
syltransferase, followed by endoproteolytic removal of the three remaining residues -AAX by
the endoproteases RCE1 in lamin B and ZMPSTE24 in lamin A, respectively, and methylation
of the new carboxyl-terminal cysteine by a methyltransferase. Prelamin A undergoes yet a sec-
ond cleavage by ZMPSTE24 deleting 15 more residues at the C-terminus including the newly
farnesylated and carboxy-methylated cysteine. (C) Processed B-type lamins are permanently
farnesylated, A-type lamins are not farnesylated. Adapted from (Dechat et al., 2008)
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1.3.2 Lamin assembly
The nuclear lamina form 10 nm filamentous meshwork as visualised in NE extracted from
amphibian oocytes (Aebi et al., 1986). In vitro, lamin assembly begins with the formation
of lamin dimers by the association of two lamin molecules by their α-helical coiled coil
domain, which is followed by protofilament formation by head to tail association of un-
staggered dimers (Figure 1.4). Unlike cytoplasmic IFs which form filaments in vitro, except
for lamin B of the C.elegans (Karabinos et al., 2003), lamin polypeptides form filamentous
bundles and paracrystalline arrays, assemblies overextend laterally giving rise to thickened
structure greater than 13 nm in diameter with striated appearance throughout their length
(Stuurman et al., 1998).
Figure 1.4: In vitro assembly of lamins - (A) Schematic representation of the domains of
the C.elegans lamin. (B) Lamin dimer formation. Two lamin monomers associate at their α-
helical coiled-coil rod domains, resulting in a long tail (cyan) with two globular heads at one
end, which contain the Ig-fold motif (red). (C) Lamin dimers further associate longitudinally
in polar head-to-tail polymers (the black arrows indicate the polarity). Adapted from (Ben-
Harush et al., 2009)
In vivo, A- and B-type lamins homo-polymers assemble from distinct layers at the nu-
clear periphery and lamins do not co-polymerise to heteropolymers in Drosophila cells
expressing exogenous lamin C (Furukawa et al., 2009). This is in agreement with yet
recent studies where it was shown that A- and B-type lamins form different filamentous
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structures in the Xenopus laevis oocyte, where B-type lamins were shown to form thin fila-
ments closely associated to the INM and A-type lamins formed thinker bundles (Goldberg
et al., 2008). Another recent study, demonstrated that A- and B-type lamins form separate
but interconnecting microdomains (Shimi et al., 2008). HeLa cells depleted of lamin B1
showed an increase in the lamina meshwork size and changes in the nucleoplasmic distri-
bution of lamin A. Moreover, B-type lamins formed separate but interconnected networks
with distinct interaction properties with A-type lamins (Shimi et al., 2008). During inter-
phase, lamin B is primarily associated with the nuclear lamina at the nuclear periphery of
vertebrate cells as well as in the nucleoplasm, however during mitosis, the nuclear lam-
ina disassemble, a process mediated by phosphorylation of nuclear lamins where lamins
become dispersed in the cytoplasm (Luscher et al., 1991; Peter et al., 1990). However
recent studies suggest that a fraction of lamin B remains associated with chromosome and
mitotic spindle formation during mitosis (Beaudouin et al., 2002; Maison et al., 1997; Tsai
et al., 2006). Most of nuclear functions related to lamins became obvious in defects of nu-
clear processes in conjunction with alteration in lamin expression or the presence of lamin
mutations.
1.3.3 The nuclear lamina: lamin association with proteins of the NE
Within the NE, lamins interact with proteins of the INM including LEM-containing proteins
first recognised in integral membrane proteins lamin associated peptide-2 (LAP2), emerin
and MAN1 (Figure 1.1) (Laguri et al., 2001). These share a conserved two helices domain
of approximately 42 residues (LEM-domain) which is also found in otefin and Lem-3, and
required for the interaction with lamins and the chromatin-binding protein BAF (barrier
to autoantigen factor) (Holmer and Worman, 2001; Lin et al., 2000; Senior and Gerace,
1988; Wagner and Krohne, 2007). Multiple isoforms of LAPs exist in vertebrates, which
interact differently with A- and B-type lamins, and are implicated in nuclear assembly by
anchoring lamins into the NE as well as mediating lamin polymerisation (Schirmer and
Foisner, 2007). One LAP, LAP1 is present in three sub-isoforms; LAP1-A, -B and -C, where
LAP1-A and -B interact with both lamin A and B in vitro, and LAP1C interacts specifically
with lamin B (Foisner and Gerace, 1993; Maison et al., 1997). Another LAP, LAP2 is present
in six isoforms α, β , γ, δ, % and ζ. Except for LAP2α and ζ, all the other isoforms contain
a single C-terminal transmembrane domain and a long nucleoplasmic N-terminal domain
(Dechat et al., 2000). LAP2β binds to lamin B1 (Foisner and Gerace, 1993; Furukawa et
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al., 1998). LAP2α lacks the transmembrane domain present in the other LAP2 isoforms
instead it comprises a large C-terminal domain and unlike the other isoforms which are
found at the INM, LAP2α is found in stable complexes with A-type lamins in the nucleo-
plasm (Dechat et al., 2000).
Emerin is another LEM-domain containing integral membrane protein that binds specif-
ically to lamin A and its association at the INM depends on the presence of lamin A
(Clements et al., 2000; Ostlund et al., 2001; Raharjo et al., 2001; Sullivan et al., 1999;
Vaughan et al., 2001). Emerin also interacts with MAN1, another INM protein as well
as the ONM proteins nesprin 1 and 2 (Mansharamani and Wilson, 2005; Wheeler et al.,
2007). MAN1 is implicated in cellular signalling and it associates with lamin A at inter-
phase and to lamin B at mitosis and like emerin, it requires lamin A for localisation at the
INM (Lin et al., 2000; Ostlund et al., 2006; Paulin-Levasseur et al., 1996).
LBR is multiple transmembrane protein of the NE, which associates, with lamin B
and its structure defines three DNA binding domains (Worman et al., 1990; Worman et
al., 1988). LBR additionally interacts with heterochromatin-specific chromosomal protein
(HP1)-type chromo-domain proteins assisting in heterochromatin attachment to the INM
(Ye et al., 1997; Ye and Worman, 1994; Ye and Worman, 1996).
Lamin A also associates with the INM integral proteins, SUN1 and SUN2 which are
expressed in somatic cells and extend to the nuclear perispace (NPS) where they interact
with KASH domain proteins of the ONM proteins including members of the nesprin family
of spectrin-repeat proteins in the ONM (also known as Syne proteins), Anc-1(Crisp et al.,
2006; Haque et al., 2006; Tzur et al., 2006). Nesprins bind to the cytoskeletal components,
actin and microtubules, effectively connecting the cytoskeleton to the nucleus and help in
nuclear positioning (Starr, 2009). In addition, lamin A is found to interact directly with
nesprin 2 at the INM in muscle cells (Zhang et al., 2005) and in vitro interacting with
nesprin-1a (Libotte et al., 2005) as well as actin in the nucleus (Sasseville and Langelier,
1998), thus directly linking the nuclear lamina to the cytoskeleton.
1.3.4 Lamins association with the NPCs
The nuclear lamina interacts with the NPCs which was already documented in 1976 (Dwyer
and Blobel, 1976). Lamins interfere with the assembly and distribution of NPCs and clus-
tering of NPCs is associated with lamin mutations (Schirmer et al., 2001; Smythe et al.,
2000). In addition, more recent data suggested a direct active role of lamin A in interacting
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with NPCs at initiation lamina assembly regions (Furukawa et al., 2009). Lamins interact
with protein subunits (nucleoporins or Nups) of the NPCs, mainly Nup153 interacts with
both A- and B-type lamins directly in vitro as well as in vivo (Al-Haboubi et al., submitted;
Smythe et al., 2000). Lamin B has also been shown to interact yet with another nucle-
oporin Nup53 (Hawryluk-Gara et al., 2005). In addition, the phosphorylation of gp210,
another nucleoporin, is required for subsequent phosphorylation of lamin polymers disas-
sembly prior to NE breakdown (Galy et al., 2008).
1.3.5 Lamin associations in the nuclear interior
In the nuclear interior, both nucleoplasmic lamin A as well as its associated polypeptides
regulate gene expression and signalling through binding with multiple gene regulatory fac-
tors such as pRb and BAF (Holaska et al., 2003; Mancini et al., 1994; Shan et al., 1992),
histones (Glass et al., 1993; Taniura et al., 1995), SREBP1 (Capanni et al., 2005; Lloyd
et al., 2002), and c-Fos (Ivorra et al., 2006). Moreover, lamin A has been found to as-
sociate with RNA splicing speckles (Muralikrishna et al., 2001), implying nuclear related
functional roles for lamin A (Dechat et al., 2008a). Lamins provide spatial organisation
for DNA synthesis, transcription and repair as well as RNA synthesis where lamin B1 is
required for RNA synthesis (Goldman et al., 2002; Tang et al., 2008). Heterochromatin
association with the nuclear lamina maintains a transcriptionally inactive state at the nu-
clear periphery (Shimi et al., 2008; Shumaker et al., 2006). In addition, lamin B interacts
directly with the proliferating cell nuclear antigen (PCNA) (Moir et al., 1994; Shumaker et
al., 2008), also it was shown that DNA synthesis foci are at overlapping regions with the
nucleoplasmic lamin A (Kennedy et al., 2000).
1.4 Nuclear lamins associated diseases
More than 24 inherited diseases are associated with the NE (Cohen et al., 2008). Muta-
tions in lamins disrupt the nuclear lamina which as a result affect normal nuclear processes
carried out by nuclear lamins (Burke and Stewart, 2006). Mutations in lamins can cause a
group of inherited diseases termed laminopathies (Liu and Zhou, 2008). Due to the large
number of lamin association with other proteins and DNA, abnormalities in lamins can
have subsequent effects on nuclear and cellular processes. Nuclear integrity and architec-
ture are affected in the presence of lamin A related mutations which result in fragile nuclei,
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membrane invaginations and nuclear blebbing (Houben et al., 2007; Lammerding et al.,
2006; Lammerding et al., 2004; Sullivan et al., 1999). Perturbed nuclear morphology is
also associated with elevated expression levels of B-type lamins (Prufert et al., 2004; Ralle
et al., 2004). Hence, altered expression of lamins can result in disruption of nuclear and
cellular processes.
1.4.1 Lamin A associated laminopathies
More than 200 mutations have been identified in LMNA accounting for more than 11 dis-
tinct inherited diseases (Figure 1.5) (Sylvius et al., 2008). Lamin A associated diseases can
Figure 1.5: Lamin A associated mutations causing laminopathies - Laminopathies causing
mutations in Lamin A/C and potential phenotypes. Missense mutations in LMNA, that result
in muscular dystrophies, can be spread throughout the whole sequence, whereas missense
mutations causing lipodystrophies are located in the Ig-fold. Substitution of a C to T at position
1824 in LMNA, as well as mutations in ZMPSTE24 (responsible for the second cleavage of the
carboxy-methylated cystein at the tail domain, (see Figure 1.3), result in a protein that lacks 50
amino acids at the C-terminal domain (progerin), and are the underlying cause of Hutchison-
Gilford progeria syndrome (HGPS). Adapted from (Worman and Bonne, 2007)
either affect striated and heart muscle tissue such as autosomal dominant Emery-Dreifuss
muscular dystrophy (AD-EDMD), dilated cardiomyopathy (DCM) and limb-girdle muscu-
lar dystrophy 1B (LMG1B) characterised by skeletal muscle weakness and wasting and
striated and smooth muscle related defects and subsequently heart failure (Bonne et al.,
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1999). Or can affect fat tissue such as Dunnigan type-familial partial lipodystrophy (FPLD)
and mandibuloacral dysplasia (MAD), characterised by aberrant adipose tissue distribution
(Boguslavsky et al., 2006). Or can affect several tissues leading to premature aging, such
as Hutchinson-Gilford progeria syndrome (HGPS) as well as atypical Werner’s syndrome,
which are characterised by loss of subcutaneous fat, decreased bone density, osteoporosis,
abnormal dentition and growth retardation (Worman and Bonne, 2007).
Apart from HGPS, most mutations of lamin A are products from an amino acid substi-
tution in LMNA (Worman and Bonne, 2007). Mutations resulting in AD-EDMD and DCM
are spread through out the lamin molecule (Bonne et al., 1999; Mounkes et al., 2005;
Speckman et al., 2000). In contrast, mutations in FPLD are clustered at the C-terminus of
lamin A, where the rod domain is not affected and therefore not disrupting lamin assem-
bly, but rather affecting interaction with binding proteins (Speckman et al., 2000; Stierle
et al., 2003). Moreover, mutations resulting in lipodystrophies result in elevated levels of
pre-lamin A (Capanni et al., 2005; Favreau et al., 2003).
Several mouse models have been generated to study disease heterogeneity resulting
from mutations in LMNA (Stewart et al., 2007a). Four mouse models for muscular dystro-
phies have been created, either lacking LMNA (LMNA−/−) or carrying a related mutation
such as, H222P and N195K (Arimura et al., 2005; Mounkes et al., 2005; Stewart et al.,
2007a). In such a model, it was shown that immortalised LMNA−/− myoblasts are impaired
in their differentiation to myotubes, leading to EDMD (Frock et al., 2006; Sullivan et al.,
1999). Other mouse models carrying missense mutations, H222P or N195K led to AD-
EDMD and DCM, respectively (Arimura et al., 2005; Mounkes et al., 2005). Cellular anal-
ysis from these mice showed abnormal nuclear morphology that led to skeletal and striated
muscle specific degeneration, which suggest that LMNA mutations cause cardiomyopathy
by disrupting the internal organisation of the cardiomyocyte and/or altering the expres-
sion of transcription factors essential to normal cardiac development, aging and function
(Arimura et al., 2005; Mounkes et al., 2005). In addition, a forth mouse model with tar-
geted expression of LMNA mutation M371K in the heart with a heart-specific α-myosin
heavy chain promoter, revealed extensive pathology with disruption of the cardiomyocytes
and abnormal nuclei (Wang et al., 2006). Hence, the expression of LMNA mutant that al-
ters nuclear morphology can cause tissue and organ damage in mice expressing the normal
complement of endogenous lamins (Wang et al., 2006).
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Four mouse models have also been established for HGPS (Maraldi and Lattanzi, 2007).
One model shows a deletion of exon 9 in LMNA (LMNA∆9/∆9) resulting in the expression
of farnesylated lamin A (Mounkes et al., 2003). Other mouse models include those that
express either homozygous (LMNAHG/HG) or heterozygous (LMNAHG/+) progerin, respec-
tively (Yang et al., 2005; Yang et al., 2006). In addition, mice were also created that lack
the enzyme ZMPSTE24 that cleaves pre-lamin A to mature lamin A (Bergo et al., 2002;
Pendas et al., 2002; Shackleton et al., 2005). These mice retain farnesylated pre-lamin
A that accumulated at the nuclear rim and showed osteoporosis and muscle weakening.
Both homo- and heterozygous expression of farnesylated pre-lamin A can lead to MAD and
progeria like syndromes (Shackleton et al., 2005).
Lamin A associated mutations can affect signalling pathways such as the Notch sig-
nalling pathway which is activated in human mesenchymal stem cells in HGPS and shows
aberrant signalling in osteogenesis, and adipogenesis (Lowry and Richter, 2007; Scaffidi
and Misteli, 2008). It was also demonstrated that pre-lamin A mutant lead to decreased
proliferation and accumulated hair bulge in stem cells with pre-lamin A as a result of com-
plete loss of the Wnt/B-catenin signalling pathway which regulates hair follicle stem cells
(Espada et al., 2008). Overall, mutations in LMNA either disrupt the assembly of lamins
into the nuclear lamina, resulting in mechanical stress and defects in nuclear architecture.
Or can alter gene expression by disrupting lamin mediated interactions nuclear regulatory
factors (Cohen et al., 2008).
1.4.2 Lamin B related diseases
Mutations in LMNB were thought to be embryonic fatal until recently when two mutations
have been identified in LMNB2 in patients with acquired partial lipodystrophy (APL) (Ca-
panni et al., 2003). Additionally, duplications in LMNB1 were identified in patients with
an autosomal-dominant leukodystrophy (ADLD) (Capell and Collins, 2006; Hegele et al.,
2006; Padiath et al., 2006). A mouse model was created with a gene trap insertion in
LMNB1 (LMNB−/−) that results in lamin B1 lacking the NLS, CAAX-box as well as a por-
tion of the rod domain which results in sever phenotype with abnormally misshapen nuclei
(Vergnes et al., 2004). Although this mutation was shown to cause local disturbances in NE
structure without causing generalized defects in nuclear organization, stiffness, and shape
stability, which was thought to be largely due to the functional redundancies of lamin B1
and B2, and the influence of lamin B1 deficiency is masked by lamin B2 (Vergnes et al.,
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2004). In the future, this issue needs to be addressed by creating lamin B1/lamin B2
double knockout cells (Stewart et al., 2007a).
1.4.3 Lamin binding proteins associated diseases
Mutations in the lamin A binding protein, emerin were first recognised in X-linked EDMD
(X-EDMD) (Bione et al., 1994). Mutations in the LBR gene can either lead to Pelger-
Huet anomaly with abnormal nuclear shape and chromatin organisation in neutrophils
(Hoffmann et al., 2002), or to the autosomal recessive Greenberg skeletal dysplasia, char-
acterised by short-limb dwarfism, ectopic bone ossification (Waterham et al., 2003). Fur-
thermore, a mutation in the MAN1 gene can cause Buschke-Ollendorf syndrome, which
is characterised by increased bone density (Hellemans et al., 2004). A rare mutation in
LAP2α Arg690Cys, which might interfere with interaction with lamin A, can cause DCM
(Taylor et al., 2005). In addition lamin A binding proteins, nesprin-1 and -2 have also
been affected in AD-EDMD as well as X-linked EDMD, in which the interactions of those
proteins with lamin A and emerin are disrupted, revealing an additional role for nesprins
in the pathology of EDMD (Wheeler et al., 2007; Zhang et al., 2007). Emerin null mouse
model has been created (Emd−/−) and demonstrated normal phenotype with slightly ab-
normal muscle regeneration, but not as severe as the phenotype associated with LMNA−/−
mice (Melcon et al., 2006; Ozawa et al., 2006).
1.4.4 Lamins and cancer
With respect to cancer, lamins may serve as biomarker because the expression levels in par-
ticular of lamin A/C are often altered in cancer tissues (Prokocimer et al., 2006). For ex-
ample, in small cell lung cancer, the levels of lamin A and C are strongly reduced, whereas
lamin B levels were not changed (Broers et al., 1993). Similarly no or reduced expression
of lamin A/C was described in gastrointestinal neoplasms, with at the same time reduced
lamin B levels (Moss et al., 1999). On the other hand, elevated levels of lamin A/C were
found in colorectal cancer patients (Willis et al., 2008) as well as in oesophageal squamous
cell carcinoma cells (Qi et al., 2008). Contrary results were found in studies regarding skin
cancer (Oguchi et al., 2002; Tilli et al., 2003). Lamin A/C levels in one basal cell carci-
noma study were reduced and elevated in another study. However, in other solid tumours
of the gastrointestinal tract such as pancreatic and hepatocellular carcinomas, lamin A/C
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and B1 levels were found unchanged (Hytiroglou et al., 1993). Contrary results were also
found in the levels of lamin expression in breast cancer (Hudson et al., 2007; Moss et al.,
1999). Recently, it was also shown that alterations of lamin B1 staining was increased with
the degree of malignancy in breast cancer tissue (Bussolati et al., 2008).
Overall, altered expression levels of lamins associated with cancer tissue demonstrate
the necessity for an intact lamina and normal nuclear related functions that are disrupted
in transformed tissue.
1.4.5 Lamins and viral infections
DNA viruses replicate in the nucleus where they assemble their viral caspids and because
of their large size (120 nm in diameter), these cannot transverse through the NPCs and
require other mechanisms to exit the nucleus (Cohen et al., 2006). These viruses utilise an
envelopment mechanism by which they form enveloped caspids through interactions with
the INM and PNS, but have to overcome the nuclear lamina meshwork, either during mito-
sis or by locally destabilising the nuclear lamina (Bukrinsky, 2004). At the onset of mitosis
lamins undergo multiple phosphorylation events to depolymerise the nuclear lamina, and
some viruses utilise kinases to phosphorylate lamins or form complexes with proteins of
the NE at interphase (Heald and McKeon, 1990; Milbradt et al., 2009; Moir et al., 2000;
Mou et al., 2008; Nigg, 1992b). For example, Herpes simplex virus-1 (HSV-1) viral caspids
that are pre-assembled in the nucleus develop a budding mechanism through the nuclear
lamina, the INM and the PNS resulting in the formation of enveloped virions that fuse into
the ONM and release its caspids into the cytoplasm (Mettenleiter, 2006). The HSV-1 viral
proteins UL31 and UL34 disrupt the nuclear lamina by inducing conformational changes in
lamin A/C (Reynolds et al., 2004). In addition, UL34 directly binds to lamin A/C and lamin
B1, and it was shown that lamin A interferes with viral infectivity and lamin B1 in addition
is required for optimal viral replication (Mou et al., 2008). Moreover, a kinase, US3 that
phosphorylates UL31 also phosphorylates lamin A and redistributes emerin along with the
viral protein UL34 to exit the nucleus (Leach et al., 2007; Mou et al., 2007). However, a
role for lamin A phosphorylation in HSV-1 viral infection has been ruled out very recently,
as it was demonstrated that US3 mediated phosphorylation of UL31 directly regulates the
enveloped caspids localisation within the INM, where it aggregates at the nuclear rim and
lead the aberrant accumulation of virions in herniations of the nuclear membrane (Mou et
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al., 2009). Moreover, recent data indicate that lamin A act as repressor for gene transcrip-
tion as well enhancer for viral gene transcription and as such it is required for HSV-1 viral
genome targeting as well as DNA replication (Lee et al., 2009; Silva et al., 2008).
Nuclear egress of the human cytomegalovirus (HCMV) is accomplished by destabilis-
ing components of the nuclear lamina using the viral proteins UL50 and UL53, respectively
(Camozzi et al., 2008). These were found in overlapping regions with mislocalised lamin
A/C and lamin B1 and several viral proteins form complexes with proteins of the NE in-
cluding LBR (Camozzi et al., 2008; Milbradt et al., 2009). The human immunodeficiency
virus-1 (HIV-1) does not require NE breakdown to enter the nucleus (Bukrinsky, 2004), the
viral protein Vpr induces changes in the nuclear lamina architecture by locally disrupting
A- and B-type lamins and NE herniations that led to cell cycle arrest (de Noronha et al.,
2001). To overcome the nuclear lamina, pre-assembled viral caspids overcome the nuclear
lamina either by directly interacting with lamins, which result in local disruption of the nu-
clear lamina or relying on phosphorylation mechanism to breakdown the nuclear lamina
and enetually egress the cell.
1.4.6 Nuclear lamina components as targets for autoantibodies
Components of the nuclear lamina, lamin A/C and B as well as the INM associated pro-
teins, LBR, LAP1/2 and MAN1 are targeted by autoantigens in autoimmune diseases, such
as autoimmune liver disease, systemic lupus erythematosus, and other related conditions
(Courvalin et al., 1990; Enarson et al., 2004; Konstantinov et al., 1996; Ye and Worman,
1994). The underlying mechanism for autoantigen recognition is unknown.
1.5 Nuclear pore complexes
The nuclear pore complexes (NPCs) are large assemblies of multiple proteins, forming
channel like structures that permit the bi-directional transport of molecules in and out of
the nucleus (Alber et al., 2007; Lim et al., 2008). Nucleocytoplamic transport through the
NPCs is mediated either by free diffusion of ions and small molecules less than 40 kDa, or
facilitated diffusion by receptor-mediated translocation of macromolecules such as RNA
and protein cargo. Thus, NPCs provide a selective highly regulated transport system
through the nucleus (Feldherr et al., 1984; Terry et al., 2007).
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1.5.1 Structural organisation of the NPC
NPCs have massive molecular weight of roughly 60-125 MDa in mammalian cells and
40-60 MDa in yeast cells (Reichelt et al., 1990; Yang et al., 1998). Nonetheless the struc-
tural organisation is evolutionarily conserved from yeast to mammals (Alber et al., 2007;
Fahrenkrog et al., 1998; Suntharalingam and Wente, 2003; Yang et al., 1998). The NPC
is composed of multiple copies of approximately 30 distinct proteins termed nucleoporins
(or Nups) arranged in sub-complexes to form the NPC (Lim and Fahrenkrog, 2006; Rout
et al., 2000; Tran and Wente, 2006). Much of the structural information about the NPC
comes from extensive structural work done on the localisation of individual Nups or sub-
complexes within the NPCs of yeast and vertebrate cells, using immuno-gold labelling,
electron microscopy (EM), cryo-EM, cryo-electron tomography (CET), X-ray crystallogra-
phy and most recently atomic force microscopy (AFM) (Beck et al., 2004; Brohawn et al.,
2008; Jarnik and Aebi, 1991; Maco et al., 2006; Stoffler et al., 1999a; Yang et al., 1998).
The 3D reconstitution of the NPC structure is obtained from EM-based studies using
negatively stained and frozen-hydrated NPCs from Xenopus oocyte NEs or frozen hydrated
yeast cells (Akey and Radermacher, 1993; Hinshaw et al., 1992; Yang et al., 1998). A
central framework (or the spoke complex) of the NPC resides in the plane of the NE (be-
tween the INM and the ONM), which has an eight fold rotational symmetry, embracing a
central pore and connected to eight cytoplasmic filaments at the cytoplamic periphery and
a nuclear basket arranged by eight filaments joint into a distal ring at the nuclear periphery
(Figure 1.6A) (Beck et al., 2004; Beck et al., 2007). The central pore has a diameter of
60-70 nm at the periphery and 45 nm in the midplane of the NPC and the NE (Beck et al.,
2004; Beck et al., 2007; Pante and Kann, 2002; Stoffler et al., 2003). This central pore
mediates the traffic of macromolecules of up to 39 nm in diameter between the cytoplasm
and the nucleus (Pante and Kann, 2002; Stoffler et al., 1999a). The NPCs peripheral chan-
nels have a diameter of 8 nm and proposed to mediate free diffusion of ions and small
molecules or even INM associated proteins (Feldherr and Akin, 1997; Soullam and Wor-
man, 1995). In addition, these peripheral channels act as a hub for central pore related
deformations (Fahrenkrog and Aebi, 2003). The total length of the NPC was calculated
to be 150 nm with an outer diameter of 125 nm based on information obtained from Dic-
tyostelium NPCs, where the cytoplamic filaments and the nuclear basket measure 35 nm
and 60 nm long, respectively, as well as the additional 50 nm for the central framework
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(Beck et al., 2004; Beck et al., 2007). A central plug which can sometime be seen in the
middle of the central pore, was thought to be a transporter in the early day (Feldherr and
Akin, 1997; Jaggi et al., 2003; Stoffler et al., 1999b), but more recently it became evident
that it represents cargo in transit (Beck et al., 2004; Beck et al., 2007; Stoffler et al., 2003).
Figure 1.6: Architecture and composition of the nuclear pore complex - (A) A consensus
model of the NPC based on a reconstruction of native NPCs embedded in thick amorphous
ice. The main structural components include the central framework (yellow), the cytoplasmic
ring moiety (blue) and attached cytoplasmic filaments (blue), and the nuclear ring moiety (or-
ange) and the distal ring (orange) of the nuclear basket. Adapted from (Fahrenkrog and Aebi,
2003). (B) Schematic representation of the sub-complex localisation and possible interactions
of nucleoporins of the mammalian NPC. Interactions confirmed by biochemical analysis and
potential associations are indicated by connecting lines. Interactions between sub-complexes
(blue lines), predicted interactions between subcomplexes based on homologues in S. cere-
visiae (dashed blue line), interactions of nucleoporins within sub-complexes (black line). c,
cytoplasm; n, nucleus. Adapted from (Lim et al., 2008)
1.5.2 Molecular composition of NPCs
Nups are found in multiple copies of 8 or higher with at least 456 Nups per yeast NPC,
forming sub-complexes (Cronshaw et al., 2002; Rout et al., 2000). The complexity of the
NPC architecture is however reduced by modularity (Alber et al., 2007). Recent work on
the NPC organisation using integrative-based design combining biophysical and proteomic
data have indicated simplicity in the composition and modularity of the NPC architecture in
yeast cells (Alber et al., 2007; Devos et al., 2006). Based on putative structure motifs found
in various Nups, the latter are classified into three groups: transmembrane, central scaffold
and peripheral FG nucleoporins, respectively (see Figure 1.6B) (Alber et al., 2007). The
19
1.6 Nup153
transmembrane group involves Nups with transmembrane α-helices and a cadherin fold
and form the outermost layer of the NPC central framework, and are believed to anchor
the NPC to the NE, such as gp210 (Mansfeld et al., 2006; Stavru et al., 2006). The central
scaffold group contains α-solenoid and α-propeller folds, these domains coordinate multi-
protein assemblies and are implicated in signal transduction, transcription regulation, cell
cycle control and apoptosis (Devos et al., 2006). More than half of the of the NPC is made
of scaffold proteins which resemble coated vesicles and these form a 16-fold repetition of
columns at least in yeast (Alber et al., 2007). Such scaffold proteins include components
of the Nup107-160 complex, Nup93 and Nup205 (Berke et al., 2004; Galy et al., 2003;
Grandi et al., 1997). The peripheral FG group consists of nucleoporins mainly harbouring
FG repeats and coiled-coil motifs. FG repeat are natively unfolded structures defined by
long stretches of hydrophobic residues comprising phenyl-alanin- glycine/lysine repeats;
FG, FXFG (x, any), GLFG (L, Leucine) usually separated by 5-50 residues of hydrophilic
linkers (Denning et al., 2003; Fink, 2005; Rout and Wente, 1994). The FG repeats have
multiple topological positions in the NPC and are involved in cargo translocation such as
Nup50, Nup153, Nup214 and Nup358 (Bayliss et al., 2000; Bayliss et al., 2002; Denning
et al., 2003; Fahrenkrog et al., 2002; Lim et al., 2006; Napetschnig et al., 2007). Other less
frequent motifs include a zinc finger motif found in Nup153 and RanBP2/Nup358 (Higa
et al., 2007) and an RNA binding motif found in Nup35 (Handa et al., 2006).
1.6 Nup153
Nup153 depicts its name from its molecular size of 153 kDa in human and Drosophila and
share similar but not identical sequence to the S. cerevisiae yNup1/2, yNup60 and the C.
elegans, npp-7, respectively (Dimaano et al., 2001; Galy et al., 2003; McMorrow et al.,
1994; Pitt et al., 2000; Sukegawa and Blobel, 1993). Nup153 is a highly dynamic glyco-
protein and has three distinct domains that represent a distinct topology along the NPC
(Fahrenkrog et al., 2002; Krull et al., 2004; Rabut et al., 2004). The N-terminal domain
(amino acids1-610) is located at the nuclear ring moiety of the NPC, and is thought to
be responsible for initiating the incorporation into the NPC specifically within amino acid
residues (NPAR) (39-339) and also implicated in the nuclear envelope targeting (NETC)
between amino acid residues (1-144) (Enarson et al., 1998). An RNA binding domain
is present within residues 250-400 (Dimaano et al., 2001). An M9-like NLS sequence is
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thought to be located at the N-terminal domain (Nakielny et al., 1999). A central zinc
finger domain is located between amino acid resides (650-880), which is comprised of
four C2-C2 type zinc fingers (Sukegawa and Blobel, 1993). The C-terminal domain of
Nup153 resides between amino acid residues (881-1475) and has approximately 28 un-
structured FG- repeats (Denning et al., 2003; Lim et al., 2007; McMorrow et al., 1994).
While the N-terminal, and the zinc finger domains have stationary localisation at the nu-
clear ring moiety and the distal ring, respectively, the C-terminal domain is flexible with
multiple associations in the NPC (Figure 1.7) (Fahrenkrog et al., 2002). It can be mapped
to the nuclear ring moiety, the distal ring and the cytoplasmic periphery of the central pore
(Fahrenkrog et al., 2002; Paulillo et al., 2005; Walther et al., 2001). The C-terminus of
Nup153 is highly implicated in nuclear transport, in an importin α/β -mediated transport,
Nup153 binds to importin-β through the FG- repeat domain (Shah and Forbes, 1998). In
addition, Nup153 also interacts with export receptors, exportins such as CRM-1 (Nakielny
et al., 1999; Walther et al., 2003a). RanGTP is implicated in the regulation of Nup153
associations with import as well as export factors, with importin-β , mRNA export, as well
as associations with other nucleoporins (Bastos et al., 1996; Higa et al., 2007; Ullman et
al., 1999; Walther et al., 2003b).
Nup153 is a highly mobile protein, the NPC exchanging with a small population in the
nucleoplasm (Daigle et al., 2001; Griffis et al., 2004). It associates with RNA polymerase I
and II and interacts with RNA (Ball et al., 2007; Griffis et al., 2004; Ullman et al., 1999)
and chromatin (Bodoor et al., 1999a; Sukegawa and Blobel, 1993). Nup153 regulates
gene transcription by its roles in chromosomal translocation and dosage compensation
(Heidenblad et al., 2008; Mendjan et al., 2006). The interaction of Nup153 with importin-
β in addition to transport related function, is implicated in NPC assembly, NE breakdown
(Harel and Forbes, 2004; Liu et al., 2003b; Prunuske et al., 2006). Moreover, Nup153 is
one the early proteins recruited to the NE post mitosis, at late anaphase (Bodoor et al.,
1999b; Haraguchi et al., 2000).
Nup153 undergoes several posttranslational modifications and during mitosis Nup153
is phosphorylated (Favreau et al., 1996). Recently, Nup153 is implicated both in early cell
cycle progression and exit and demonstrated to have distinct roles during mitosis (Mackay
et al., 2009). Manipulating the extent of Nup153 reduction led to defects either at an early
stage of mitosis or delay at a later stage in lesser severe levels (Mackay et al., 2009). Its
zinc finger domain is also involved in NE breakdown by interacting with COPI complex
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Figure 1.7: Domain localisation of Nup153 - A schematic representation of the NPC illus-
trating the localisation of Nup153 domains based on immunolocalization data obtained either
with domain-specific antibodies or by using antibodies against epitope-tagged Nup153 incor-
porated into Xenopus NPCs antibodies. The N-terminal domain (orange) and the zinc finger
domain (blue) are stationary at the nuclear ring moiety and the distal ring respectively, whereas
the C-terminal FG-repeat domain (green) is highly mobile. It can be located at the nuclear ring
moiety (left), at the distal ring (middle), or even at the cytoplasmic periphery of the central
pore (right). Adapted from (Fahrenkrog et al., 2002)
that is recruited in NE disassembly (Liu et al., 2003b). In apoptosis, Nup153 is cleaved
at the N-terminal domain between residues 36-391 by caspase 3 (Buendia et al., 1999;
Ferrando-May et al., 2001). In addition, it is degraded during viral infection and oxidative
stress (D’Angelo et al., 2009; Gustin and Sarnow, 2001; Kodiha et al., 2004).
Nup153 interacts with other nucleoporins, mainly Tpr at the nuclear basket, where Tpr
requires Nup153 for its localisation (Hase and Cordes, 2003). However, Nup153 recruit-
ment to the NPC does not require the nuclear basket protein Tpr for assembly (Hase and
Cordes, 2003). Nup153 requires the Nup107/Nup160 complex for incorporation in the
NPC, specifically its interaction with Nup160 at the N-terminal domain between residues
210-338 as well as the interaction with Nup96 and Nup133 (Boehmer et al., 2003; Krull et
al., 2004; Vasu et al., 2001; Walther et al., 2003a). Nup153 also interacts with Nup62 at
interphase (Stochaj et al., 2006). Nup153 is implicated in anchoring NPCs to the nuclear
lamina due to an interaction with lamin B (Smythe et al., 2000; Walther et al., 2001) and
lamin A (Al-Haboubi et al., submitted).
Nup153 is essential for cell viability (Galy et al., 2003; Harborth et al., 2001) and it is
overexpressed in retinoblastoma with 6p genomic gain, compared with the normal adult




The passive permeability of the NPCs is defined by the diameter of the pore measuring 70
nm at the periphery and 45 nm in the NE midplane (Keminer and Peters, 1999). Each
NPC permits a flow of 100 MDa/s in highly selective manner (Ribbeck and Gorlich, 2001).
The translocation of molecules greater than 40 kDa through the NPC is limited to cargo
harbouring specific nuclear localisation signal (NLS) or nuclear export signal (NES) motifs
that are recognised by transport receptors which mediate cargo passage through the NPC
by means of hydrophobic interactions with FG domain containing Nups (FG-Nups) (Bayliss
et al., 2000; Bayliss et al., 2002; Lange et al., 2007; Stewart, 2007; Strawn et al., 2004;
Suntharalingam and Wente, 2003). FG-Nups form a diffusion barrier, whereby only cargo
carrying transport-related signals could traverse though the NPCs (Lange et al., 2007;
Macara, 2001). FG-Nups exist in multiple copies per NPC, and are comprised of up to 50
repeats, which yield in approximately 190 FG-repeat domains per FG-Nup and a total of
2700 FG motifs per NPC (Peters, 2009). However, half of the FG-repeats can be removed
without affecting the overall protein transport (Strawn, 04).
Nuclear transport receptors involve a large group of structurally related members of
karyopherins (importins, exportins, or transportins) (Figure 1.8) (Pemberton and Paschal,
2005). Most importin-β isoforms bind to cargo directly, while the importin-β1 isoform
employs specific adaptors, such as importin-α, for cargo recognition (Gorlich et al., 1996).
Importin-β contains 5 binding sites for FG-Nups based on X-ray crystallography and 10
binding sites based on molecular modelling (Bayliss et al., 2000; Bayliss et al., 2002; Is-
gro and Schulten, 2005; Isgro and Schulten, 2007). The directionality of the transport
for importin-β isoforms is accomplished via the small guanosine triphosphatase (RanGTP)
and also be influenced by the importin-β binding sites with FG-Nups (Stewart, 2007). Ran
interacts with importin complexes, on the nuclear site RanGTP is found in a higher con-
centration where it destabilises import complexes and facilitates export complex formation,
once in the cytoplasm it is hydrolysed to RanGDP along with RanBP1 and RanBP2/Nup358
(Fried and Kutay, 2003; Weis, 2003). Leucine rich NES are recognised by CAS and CRM1,
where CAS helps in recycling importin-α from the nucleus, and CRM1 mediates the export
of RNA as well as proteins (Fornerod et al., 1997; Kutay et al., 1997). Proteins with a
NES motif form a complex with CRM1 and combined with RanGTP are exported from the
nucleus by interacting with Nup98 FG-repeats, and are the transported protein is released
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into the cytoplasm following the hydrolysis of RanGTP to RanGDP by RanGAP (Powers
et al., 1997). Nup358/RanBP2 and Nup214 are also involved in CRM1 mediated export
mechanism (Bernad et al., 2006; Bernad et al., 2004).
Several models have been proposed to explain the selectivity barrier of the NPC (Fahren-
krog and Aebi, 2003; Lim et al., 2008). The virtual gating model predicts an entropic
barrier formed by fluctuations of the unfolded FG-Nups, which form filament-like struc-
tures on both sides of the NPCs (Rout et al., 2000). Nuclear transport receptors bind to
FG-repeats and saturate transport complexes at the NPC, overcoming the entropic barrier
and increasing the probability of diffusion through the NPC (Rout et al., 2003). This is
in agreement with the oily-spaghetti model that proposed a repulsive gate formation in
the NPC, repelling non-FG-binding molecules, hence prohibiting the translocation of non
binding proteins (Macara, 2001).
Another model, the selective phase partitioning model predicts that intermolecular hy-
drophobic interactions between FG-Nups create a selective permeability barrier that pro-
hibits free diffusion through the NPC (Ribbeck and Gorlich, 2001). In this model, the NPC
acts as a physical barrier where the FG-Nups form a sieve-like meshwork that can be dis-
solved by a solubility diffusion process mediated by transport receptors that locally dissolve
the barrier and permit passage of receptor-cargo complexes (Frey et al., 2006). FG-repeats
of the yeast Nsp1p (GLFG) in saturated amounts form a gelatinous (hydro-gel) meshwork
that reproduces the permeability properties of the NPC in vitro (Frey and Gorlich, 2007).
Another model, the reduction of dimensionality model refers to a two dimensional walk
whereby transport receptors move through the NPC by interacting with the FG-repeats
through out the innermost layer of central framework of the NPC to the nuclear basket.
The model predicts the existence of a selectivity filter in the central channel, which is also
generated by the FG-repeats with an unobstructed narrow tube in the centre that would en-
able the diffusion of small molecules (Peters, 2005). A two-gate model of NPC architecture
featuring a central diffusion gate formed by a meshwork of cohesive GLFG nucleoporin fil-
aments and a peripheral gate formed by repulsive FxFG nucleoporin filaments (Patel et al.,
2007). This is supported by recent data which demonstrated that the FG-repeat domain
of Nup153 form polymer brushes that undergo a reversible collapse upon the addition of
nuclear transport receptors in vitro with entropic repulsion properties, the reversible FG
domain collapse model (Lim et al., 2007; Lim et al., 2006).
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Figure 1.8: Nuclear import and export cycles mediated by Ran GTP - Nuclear import of
cargo is initiated at the cytoplasmic importins (red), which interact with cargo carrying an
NLS. The importin-cargo complex translocates the cargo into the nucleus via interactions with
the NPC. Inside the nucleus, RanGTP dissociates the importin-cargo complex from the NPC.
Importins are recycled back to the cytoplasm by means of RanGTP hydrolysis. Nuclear export
is mediated by export receptors (blue) that recognise NES and require the presence of RanGTP.
Once in the cytoplasm, the complex is dissociated upon RanGTP hydrolysis. c, cytoplasm; n,
nucleus. Adapted from (Fahrenkrog, 2006)
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The NE of metazoan cells undergoes open mitosis to allow the spindle microtubules, which
are assembled in the cytoplasm, to gain access to the mitotic chromosomes in the nucleus
(Figure 1.9) (Stewart et al., 2007b). An increase of the NPCs permeability is an early
sign of the NPC disassembly prior to NE breakdown (Lenart et al., 2003). Once the NPCs
are disassembled, holes are formed in the nucleus, followed by redistribution of nuclear
membranes into the ER and ultimately the disassembly of the nuclear lamina (Beaudouin
et al., 2002). The process of NE disassembly is accompanied by the phosphorylation of
multiple NE related components, such as the nuclear lamina (Gerace and Blobel, 1980), as
well as components of the NPCs, including gp210 as well as Nup153 (Favreau et al., 1996;
Galy et al., 2008). Once the NPCs are dismantled, some nucleoporins are recruited to
the cytoplasm and others reassemble around the segregated chromosomes, or recruited to
kinetochores mitotic spindle assembly, such as Nup358 and Nup107-160 complex (Dawlaty
et al., 2008; Salina et al., 2003; Zuccolo et al., 2007). The latter is also implicated in
correct spindle assembly possibly via interactions with spindle-associated proteins (Orjalo
et al., 2006). For example, the mitotic spindle checkpoint protein complex MAD1-MAD2 is
bound to the yeast homoloug of Nup35 (Nup53p in yeast) through interactions with MAD1
and MAD2 in interphase and is released from kinetochores upon phosphorlyation of MAD1
by Nup53p at the onset of NE breakdown and mitosis (Iouk et al., 2002). Recently, the
nuclear basket protein Tpr was demonstrated to interact directly with the mitotic spindle
checkpoint proteins MAD1 and 2 as well (Lee et al., 2008). In addition, Nup153 is required
at early mitotic stages for cell cycle progression as well as at the end of mitosis (Mackay et
al., 2009). The disassembly of Nups from the NPCs is thought to occur in stepwise manner.
Nup98 and Nup50 are among the earliest Nups released, followed by Nup153, Nup358
and gp210 (Belgareh et al., 2001; Joseph et al., 2004; Prunuske et al., 2006; Salina et
al., 2003). Ultimately, Tpr, Nup96 and another population of Nup153 and Nup107-160
sub-complex are recruited in mitosis (Hase and Cordes, 2003; Loiodice et al., 2004).
1.8.1 NPC assembly
NPCs undergo two assembly phases, one at mitosis and another during interphase (Het-
zer et al., 2005). NE reassembly commences in anaphase, with stepwise recruitment of
NE components, when the NE reforms around the segregated chromosomes where several
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Nups are recruited to chromatin in a sequential manner starting in early anaphase (Bodoor
et al., 1999b; Sheehan et al., 1988; Ulbert et al., 2006). The assembly of the NPCs has
to be spatially organised and restricted to chromatin surface (Antonin et al., 2008). Dis-
tinct Nups bind to chromatin at an early mitotic stage; these are the pore forming Nups,
ELYS/Mel28 as well as the Nup107-160 sub-complex (Fernandez and Piano, 2006; Franz
et al., 2007; Glavy et al., 2007; Rasala et al., 2006). Recent data suggested a step wise
recruitment initiated by AT-rich chromatin regions with ELYS, then the Nup107-160 com-
plex followed by POM121 and NDC1 containing membrane vesicles and then other Nups
including Nup93 and Nup62 complexes (Bodoor et al., 1999b; Rasala et al., 2008). This
is followed by the appearance of INM proteins and the formation of a continuous dou-
ble membrane. These membrane components originate in the peripheral ER network.
NPC proteins also play a crucial role in membrane assembly. Interplay between Nup107-
160 and the NPC membrane protein POM121 seems to function as a membrane assembly
checkpoint, which ensures that a sealed NE does not form in the absence of functional NPCs
(Antonin et al., 2005). This is followed by the recruitment of other Nups, Nup93, Nup62
subcomplex and later the peripheral Nups; Nup214, Nup50, Nup153 and Tpr and gp210
(Bodoor et al., 1999b; Burke and Ellenberg, 2002; Hase and Cordes, 2003). Although
small pool of Nup153 as well as Nup50 is already seen at an earlier stage associated with
chromatin (Dultz et al., 2008).
Recent studies showed that A- and B-type lamins do not co-polymerise in the nuclear
lamina and have separate functions during NE assembly with lamin C is mainly involved
in NPC distribution (Furukawa et al., 2009) which contradicts with previous studies that
showed that lamin A is recruited to the NE after assembly of all the Nups and lamin B
(Moir et al., 2000b). Assembly of Nup153 and POM121 occurred earlier than lamin B1 re-
cruitment and followed by lamin import (Daigle et al., 2001; Hetzer et al., 2000). Overall,
disruption in lamin assembly or levels did not interefer with NE and NPC assembly (Daigle
et al., 2001; Newport et al., 1990; Steen and Collas, 2001). NPCs can also assemble de
novo (D’Angelo and Hetzer, 2006). Furthermore, newly synthesised nucleoporins are in-
serted into the intact NE during S-phase, which results in the doubling of the number of
NPCs prior to the next cell division and second during interphase in which cells double in
their number of NPCs in preparation for the next round of division (Antonin et al., 2008).
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Figure 1.9: Assembly of nuclear pore complexes - Schematic drawings of the nuclear enve-
lope (NE) and nuclear pore complexes (NPCs) during mitosis and interphase. During mitosis
NE reassembly commences at early anaphase with sequential recruitment of structural NPC
components, such as ELYS/Mel28 and the Nup107-160 sub-complex, to chromatin. NPCs
assemble de novo from newly synthesised nucleoporins inserted into intact NEs during inter-
phase. Adapted from (D’Angelo and Hetzer, 2008)
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DNA viruses utilise viral proteins to gain access to the host DNA machinery, either by di-
rectly interacting with distinct Nups or import mediated mechanisms to facilitate nuclear
transport (Trotman et al., 2001). Adenoviruses have a diameter of 70-100 nm and asso-
ciate with microtubules that direct the viral caspids to the ONM of the NE (Suomalainen et
al., 2001; Suomalainen et al., 1999). At the NE, these viral caspid proteins either initiate
interactions with distinct Nups, such as the direct association of adenovirus with Nup214
(Trotman et al., 2001). Or become import competent by having an NLS for their nuclear
delivery and most viral caspid proteins of adenoviruses as well as paroviruses contain an
NLS (Saphire et al., 2000; Vihinen-Ranta et al., 2002; Wodrich et al., 2006). Relying on an
importin-mediated mechanism for their transport is also described for other DNA viruses
such as, herpes viruses, hepadnaviruses and papoviruses (Kann et al., 1999; Nelson et al.,
2000; Ojala et al., 2000). Most retroviruses have an RNA genome but employ DNA for
their replication and hence require nuclear entry and rely on mitosis except for lentiviruses
including HIV-1 (Lewis and Emerman, 1994). Once in the cytoplasm, the HIV-1 RNA
genome is transcribed into DNA, which is in a complex with an integrase (IN), a reverse-
transcriptase, a matrix protein (MA) and an accessory protein (Vpr), respectively (Steven-
son, 1996). In addition to having both nuclear import as well as export in the MA (Dupont
et al., 1999; Haffar et al., 2000), the HIV-1 Vpr is imported by Nup153 interactions with
importin-β (Varadarajan et al., 2005). Recently, HIV-1 IN was shown to interact directly
with the C-terminal domain of Nup153 (Woodward et al., 2009). In addition, HIV-1 Rev is
an RNA binding protein which is also imported through Nup358- transportin mechanism
and acts as an export factor as well, mediating transport of viral RNA in an NES/exportin-1
(or known as CRM-1) dependent transport to the cytoplasm, possibly through interactions
with Nup98 and Nup214, respectively (Fischer et al., 1995; Fornerod et al., 1997; Hut-
ten et al., 2009; Neville et al., 1997; Zolotukhin and Felber, 1999). RNA viruses usually
replicate in the cytoplasm, except for influenza virus which requires the host DNA splicing
machinery which is transported to the nucleus by importin-mediated mechanism through
the NPC (Wu et al., 2007), whereby viral ribonucleoproteins contain non-conventional NLS
motifs (Martin and Helenius, 1991). Another RNA virus, vesicular somatitis virus (VSV),
which belongs to rhabdoviruses, replicates in the cytoplasm, and hijacks the nucleocyto-
plasmic transport system (Fontoura et al., 2005). It employs its own matrix protein M
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to block cellular RNA export, by forming a ternary complex with RAE1, an mRNA export
factor, and Nup98, respectively (Fontoura et al., 2005). Nup153 among other Nups are
targeted in viral infections of enteroviruses most commonly poliovirus, rhinoviruses either
by proteolysis of Nup153 and Nup62 (Belov et al., 2004; Gustin and Sarnow, 2001) or by
phosphorylation of Nup62 and Nup98 which aborts transport via these Nups (Porter and
Palmenberg, 2009). Other RNA viruses interfere with normal phosphorylation signaling,
such as cardioviruses, which employ leader proteins that interfere with phosphorylation
pathways (Bardina et al., 2009).
1.9.1 Nucleoporins related cancer and other diseases
The main function of the NPCs is nucleocytoplasmic transport and a tight regulation of
transport is essential for cell homeostasis. Alterations in components of the NPC or the
nuclear transport process have a strong impact on cell growth and survival and have been
associated with several diseases including cancer (Kau et al., 2004; Poon and Jans, 2005)
and the rare autosomal recessive disorder tripe A syndrome (Cronshaw and Matunis,
2004). Defects in nuclear transport linked to cancer and tumourgenesis can be through
the unmasking of normally hindered NLS and NES of transcriptional activators. Abnor-
mal nuclear localisation of the transcriptional activator NF-κB which is usually in com-
plex in the cytoplasm where its NLS is hindered is prominent in cancer cells (Beg et
al., 1992) and elevated levels of NF-κB in the nucleus is associated with multiple can-
cer types including Hodgkin’s lymphoma and childhood acute lymphoblastic leukaemia
(Rayet and Gelinas, 1999). NES unmasking is implicated in mutations in the tumour sup-
pressor INI1/SN5 (integrase interactor 1) which is a member of the mammalian SWI/SNF
chromatin-remodelling complex. Mutations affecting its NES, in particular, a dominant-
negative form of INI1, which is mislocalised to the cytoplasm, can lead to malignant and
atypical teratoid rhabdoid tumours (Craig et al., 2002). Distinct Nups are also implicated
in cancer as fusion products of chromosomal translocations with several oncogenes that
lead to transcriptional activation of cellular signalling such as Nup98 and Nup214 in acute
and chronic myeloid leukaemia (De Keersmaecker et al., 2008; Fornerod et al., 1995;
Moore et al., 2007). Fusion products led to aberrant transcription, decrease in differenti-
ation and increase in proliferation related fusion proteins as these proteins retained their
FG-repeat domain that initiate interactions with other transcription activating factors such
as CREB (Kasper et al., 1999). A recently discovered component of the NPC is ALADIN and
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mutation in its gene is associated with triple A syndrome (Cronshaw and Matunis, 2004).
Another important component of the NPC, which is assigned as a tumour marker in can-
cer, is Nup88 (Emterling et al., 2003). The expression levels of Nup88 were demonstrated
to correlate with severity of tumourgenesis in colon cancer and tumour aggressiveness in
breast cancer, respectively (Agudo et al., 2004; Emterling et al., 2003). In addition, re-
cent data suggested a possible direct interaction of Nup88 with NF-κB, supporting earlier
interaction data from the Drosophila homolog (Takahashi et al., 2008; Uv et al., 2000;
Xylourgidis et al., 2006).
1.9.2 NPCs components as targets for autoantibodies
As for the nuclear lamina, components of NPCs are targets for autoantibodies in human au-
toimmune diseases (Enarson et al., 2004). NPCs subunits gp210, Nup62, Nup358, Nup153
and Tpr are targeted in autoimmune liver diseases, systemic lupus erythematosus and other
related diseases. The underlying mechanism for this is not clear but molecular mimicry has
been suggested, in particular it was demonstrated that a region in the C-terminal domain
of Nup153 shows similarity with a hepatitis B virus (HBV) DNA polymerase domain (Gre-
gorio et al., 1999). In addition, gp210 also shows transmembrane domain similarity with
a number of viral enveloped proteins (Greber et al., 1990).
1.10 Concluding remarks
Due to the large interconnected network of proteins associated with the NE, hence, com-
plications arise in mutations associated with distinct protein components of the NE. Both
the nuclear lamina and NPCs are major structural and functional components of the NE.
On one hand, nuclear organisation and stability as well as bridging to the cytoskeleton is
achieved by components of the nuclear lamina. On the other hand, the NPCs offer a highly
regulated nucleocytoplamic transport. Essential nuclear functionality is perturbed in mu-
tations associated with NE components, which are well demonstrated in laminopathies
and other related diseases. The nuclear lamina and NPCs are hijacked during viral infec-
tions and cancer. Hence, understanding the molecular mechanism behind NE mediated
interactions help to relate to disease outcome.
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The nuclear envelope (NE) represents a physical barrier around the nucleus and it assem-
bles from inner and outer nuclear membrane proteins, nuclear pore complexes (NPCs) and
the nuclear lamins. The nuclear lamina, which is composed of lamins and inner nuclear
membrane proteins, is crucial for maintaining the structural integrity of the nucleus and for
positioning of NPCs within the NE. The nucleoporin Nup153 has previously been reported
to bind to B-type lamins, the specificity of this interaction, however, is not well established.
Here we have carried out solution-binding and immunoprecipitation assays to further char-
acterise the interplay between Nup153 and nuclear lamins. Our in vitro binding assays
revealed that Nup153 exhibits binding sites for both A-and B-type lamins. Moreover, we
found that the N-terminal domain of Nup153 as well as its C-terminal domain associates
with the Ig-fold motif in the tail domain of nuclear lamins. Similarly, antibodies against
Nup153 co-precipitate A-and B-type lamins from HeLa nuclear extracts. In addition, we
show that the binding of Nup153 to nuclear lamins requires distinct residues in the N-
terminal domain of Nup153. Whereas lamin A exhibits multiple binding sites between
residues 39 to 339, the so-called nuclear pore association region (NPAR) of Nup153, bind-
ing of B-type lamins requires residues 2 to 339. Our results indicate a far more intricate
interplay between Nup153 and nuclear lamins than previously accepted.
2.2 Introduction
Embedded within the nuclear envelope (NE) of eukaryotic cells are the nuclear pore com-
plexes (NPCs), 125 MDa supra-molecular structures which facilitate the passage of macro-
molecules in and out of the nucleus (Lim et al., 2008). NPCs are made up of about 30
different proteins termed nucleoporins (or Nups), which are typically found in multiple
copies due to an eight-fold rotational symmetry of the NPC and which assemble into dis-
tinct sub-complexes (D’Angelo and Hetzer, 2008; Lim and Fahrenkrog, 2006). The nu-
cleoporin Nup153 is a highly dynamic glycoprotein being involved in multiple nuclear
processes, such as nuclear protein import, RNA export, nuclear assembly/disassembly and
mitosis (Ball and Ullman, 2005; Daigle et al., 2001; Griffis et al., 2004; Liu et al., 2003;
Mackay et al., 2009; McMorrow et al., 1994). Moreover, recent findings have demon-
strated the importance of Nup153 in gene regulation as it is implicated in chromosomal
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translocations as well as dosage compensation (Heidenblad et al., 2008; Mendjan et al.,
2006; Orlic et al., 2006). Nup153 possesses a distinct domain topology along the NPC
with the amino (N)-terminal domain (residues 1-610 of human Nup153) stationary lo-
calised to the nuclear ring moiety of the NPC (Fahrenkrog et al., 2002; Walther et al.,
2001). This N-terminal domain harbours an M9-like nuclear localisation signal (Nakielny
et al., 1999), a nuclear envelope targeting cassette (NETC; residues 1-144), the NPC as-
sociation region (NPAR; residues 39-339) as well as a RNA binding domain (Bastos et al.,
1996a; Enarson et al., 1998; Nakielny et al., 1999; Ullman et al., 1998). A central zinc
finger domain (residues 650-880) is stationary anchored to the distal ring of the nuclear
basket of the NPC (Fahrenkrog et al., 2002). The carboxyl (C)-terminal domain of Nup153
(residues 881-1475) is highly flexible and dominated by about 30 phenylalanine-glycine
(FG)-repeat motifs, which have little secondary structure, i.e. natively unfolded, and me-
diate the interaction of Nup153 with soluble nuclear transport receptors (Ball and Ullman,
2005a; Lim et al., 2006; Lim et al., 2007). This C-terminal domain is highly flexible and
has been demonstrated to shuffle between the nucleoplasmic and the cytoplasmic face of
the NPC (Fahrenkrog et al., 2002; Paulillo et al., 2005). Nuclear lamins belong to the
family of intermediate filament (IF) proteins (Szeverenyi et al., 2008) and are the main
constituents of the nuclear lamina (Aebi et al., 1986). They play an important role in
various nuclear processes, such as determining nuclear size and shape, NPC positioning,
transcription, DNA replication and mitotic spindle assembly (Salina et al., 2001; Vaughan
et al., 2000). In eukaryotes, lamins are subdivided into A and B types. The major A-type
lamins, lamin A and C, originate from alternative splicing of a single gene LMNA gene,
whereas lamin B1 and B2 are encoded by two genes LMNB1 and LMNB2, respectively
(Fisher et al., 1986). While B-type lamins are ubiquitously expressed, A-type lamins are
found only in differentiated cells. Like all IFs, lamins consist of α-helical coiled coil rod do-
main flanked by two globular non- helical N- (head) and C- (tail) terminal domains (Heins
and Aebi, 1994). The tail domain encompasses (i) a nuclear localisation signal (NLS) that
targets the lamins into the nucleus, (ii) a unique highly conserved immunoglobulin like
fold (Ig-fold) that is involved in protein-protein interactions and chromatin binding (Moir
et al., 1994; Shumaker et al., 2008; Stierle et al., 2003), and (iii) a -CAAX box required for
posttranslational lipid modification (Schirmer et al., 2001). Mutations in the human LMNA
gene account for at least 18 distinct heritable diseases, collectively termed laminopathies
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(Worman and Bonne, 2007). These include muscle diseases, such as Emery-Dreifuss mus-
cular dystrophy (EDMD) and dilated cardiomyopathy (DCM), metabolic diseases, such as
familial partial lipodystrophy (FPLD) or premature aging syndromes as Hutchinson-Gilford
progeria syndrome (HGPS). The disease causing mutations are distributed through out the
LMNA gene, but most mutations known to date are located in the tail domain of the pro-
tein, in particular in the Ig-fold (Shumaker et al., 2005). Previous reports showed that
Nup153 interacts with Xenopus lamin B3 (also known as LIII) in cell-free extracts from
Xenopus eggs (Smythe et al., 2000). Blot overlay assays furthermore revealed that Nup153
binds directly via its C-terminal FG-repeat domain to LIII, but not to lamin A or the lamin-
binding protein emerin (Smythe et al., 2000). Nup153 recruitment to the NPC is strictly
lamin-dependent, as Nup153 incorporation into the NPC failed in cells lacking an intact
lamina (Smythe et al., 2000). Moreover, Nup153 localisation is often perturbed in cells
expressing disease-related lamin A mutants (Hubner et al., 2006b). Based on the recent
findings that FG-repeat domains are natively unfolded (Denning et al., 2003; Denning et
al., 2002), dynamic and flexible within the NPC (Fahrenkrog et al., 2002; Paulillo et al.,
2005) and dispensable for viability (Strawn et al., 2004), we speculated that the FG-repeat
domain of Nup153 is unlikely to present the only interaction site between Nup153 and the
nuclear lamins. We demonstrate here that Nup153 binds to both A- and B-type lamins,
in particular to the Ig-fold. Using solution-binding assays, we revealed that this binding
is not part of a nuclear import complex. Furthermore, both the N- and the C-terminal
domain of Nup153 interact with the Ig-fold of lamin A and B and the interaction is abol-
ished when particular amino acid residues of Nup153 are deleted. Importantly, lamin A
and lamin B association with the N-terminus of Nup153 necessitates differing amino acids.
The experiments described here demonstrate that the Nup153-lamin interplay is extremely
variegated and imply functional differences.
2.3 Experimental Procedures
All experimental procedures were carried out at room temperature, unless otherwise stated.
2.3.1 DNA constructs
Bacterial expression of recombinant GST-HA-Nup153-His fragments was from pGEX 4T-
3 and pGEX 6P-1 vectors. HA-Nup153-His fragments were PCR amplified from the HA-
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Nup153 encoding eukaryotic expression vectors (Enarson et al., 1998) and cloned into the
BamHI site of the pGEX vectors. The 3’ primers for these PCR reactions encoded a 6xHis
tag, whereas the HA-tag was part of the eukaryotic expression constructs and is separated
from the Nup153 aa3 (Ser) by a XhoI site. Certain fusion constructs were also obtained by
first cloning PCR-amplified Nup153-fragments into pBluescript and from there into pGEX-
HA-vectors or by direct ligation of the fragments cut out from the eukaryotic expression
vectors into pGEX-HA-Nup153-His opened with XhoI and NotI. Transfer of the Nup153
encoding fragments from pGEX 4T-3 to pGEX 6P-1 was done using the BamHI cloning sites
and allowed the expression of GST-Nup153 fusion fragments which can be cleaved with
precission protease. pGEX-C1-Nup153 (aa 1001-1385) was obtained from Katie Ullman
(Fahrenkrog et al., 2002).
2.3.2 Antibodies
The following antibodies were used in Western blot analysis. Mouse monoclonal SA1 (1:50
dilution; a gift of Brian Burke, University of Calgary, Calgary, Alberta, Canada (Bodoor et
al., 1999)) or 7A8 (1:50; a gift from Volker Cordes, University of Heidelberg, Heidel-
berg, Germany (Cordes et al., 1993)) against the C-terminus and the N-terminus of hu-
man Nup153, respectively. Mouse monoclonal importin-α (l1784; 1:1000, Sigma-Aldrich,
St.Louis, MO, USA) and -β (l2534; 1:1000, Sigma-Aldrich). Rabbit polyclonal anti-lamin
B1 (ab16048; 1:3000; Abcam, Cambridge, MA, USA) recognises an epitope within residues
400-500, Xenopus lamin B2, Xenopus lamin A (monoclonal) and rabbit polyclonal 324
against human lamin A peptide cVTVTRSYRSVGGSG, which corresponds to residues 620-
633; (1:1000). A rabbit polyclonal human lamin B2 antibody (328) against a specific
peptide cTVKKSSVMRENENG, which corresponds to residues 576-589 (1:1000). All sec-
ondary antibodies were obtained from Sigma-Aldrich.
2.3.3 Recombinant protein expression and purification of glutathione
S-transferase (GST) coupled Nup153 fragments
GST-fusion proteins of Nup153 were expressed in E.coli BL21-DE3 codon (+) cells. A 5ml
over night culture was used to inoculate 1-3 litres of LB medium and grown at 37 ◦C until
an optical density at 595 nm of 0.6 was reached. Protein expression was next induced
by the addition of 0.1 mM IPTG and cells were grown in culture for 3 hours at 37 ◦C and
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shaking at 180 rpm. Bacterial pellets were collected by centrifugation at 5000 rpm for 10
min at 4 ◦C (SLA3000, Sorvall). The pellet was resuspended in phosphate buffered saline
(PBS) containing 0.5 mM PMSF, 5.0 µg/ml aprotinin and 5.0 µg/ml leupeptin, lysed by
sonication and cleared centrifugation at 11000 rpm (20 000 g) for 45 min at 4 ◦C. The su-
pernatant was next incubated with glutathione sepharose-4B (GE Healthcare Biosciences,
Uppsala, Sweden) for 2 hours while shaking, transferred onto a ply-prep chromatography
column (Bio-Rad laboratories, CA), washed by the addition of PBS (binding buffer) 3-4
volumes and eluted using elution buffer (20 mM glutathione (reduced form, AppliChem,
Darmstadt, Germany), 100 mM Tris pH 8.0, 120 mM NaCl, 10 mM DDT). In a second pu-
rification step, proteins were loaded on a nickel column (Ni-NTA agarose, Qiagen GmbH,
Hilden, Germany), washed and eluted using 500 mM Imidazole, collected fractions were
dialysed against PBS and stored in aliquots at -80 ◦C.
2.3.4 Cell culture
HeLa cells were maintained in Dulbecco’s modified Eagle medium (Gibco/Invitrogen, Life
Technologies Corporation, CA), supplemented with 10% FBS (PAA), 100-units/ml peni-
cillin/ 100 µg/ml streptomycin (Gibco/Invitrogen) and 2 mM glutamine (Gibco/Invitrogen).
The cells were grown in a monolayer in a humidified 37 ◦C incubator supplied with 5%
CO2.
2.3.5 Coupled in vitro transcription and translation
Coupled in vitro transcription and translation of proteins was performed using the TNT®
quick- translation system kit (Promega, Madison, WI, USA) following the manufactures
protocol. In brief, 40 µl of quick master mix were incubated with 2 µg of plasmid DNA,
1-2 µg/µl of aprotinin and leupeptin, and 4 µl of [35S]-methionine (either L-Methionine
500 µCi; GE-Amersham Biosciences, Buckinghamshire, UK, or Easytag Methionine-[35S];
Perkin Elmer Life Sciences, Boston MA, USA) at 30 ◦C for 90 min. 1µl of RNase inhibitor
(RNasin N251A; Promega, Madison WI, USA) was added just 5 min prior to terminating
the reaction, as specified by the manufacturer’s protocol. 5 µl of product was mixed with




2.3.6 Solution binding assays
Solution binding assays were performed as previously described (Walter et al., 2006).
2.3.7 Immunoprecipitation assays
HeLa cell extracts either commercially available (HeLa (IP) cell lysate, sc-24785, Santa
Cruz Biotechnology, Santa Cruz, CA) or from HeLa cells cultured in our laboratory were
used. Cells were lysed using either RIPA buffer (sc-24948, Santa Cruz Biotechnology) or
in 50 mM Tris-HCl, pH 7.2, 250 mM NaCl, 0.1% Igepal, 2 mM EDTA, 10% glycerol and
protease inhibitor cocktail (Roche Diagnostics, Indianapolis IN, USA). The cell pellet was
resuspended in 500 µl ice-cold lysis buffer and homogenised using a Dounce homogeniser.
The lysate was then centrifuged at full speed using a tabletop centrifuge for 30 min. Next,
the supernatant was pre-cleared by incubating with 20 µl of pre-equilibrated protein A-
agarose (sc-2001, SantaCruz Biotechnology) for 1 hour at 4 ◦C rotating and the super-
natant was subsequently incubated with 1µg of antibody and rotated for 2 hr at 4 ◦C. To
immobilise the antibody, the mixture was incubated with 60 µl of protein A-agarose and
rotating at 4 ◦C for 2 hours. The beads were washed 3-4 times with lysis buffer and 30 µl
of 3x sample buffer was added to beads and boiled while mixing at the same time to elute
bound fractions.
2.3.8 SDS-PAGE and immunoblotting
Protein samples were resolved by SDS-PAGE and either stained with Coomassie blue or
transferred to PVDF membrane and probed with the appropriate antibodies and developed
using the Western Lighting CDP-Star® Chemiluminescence Reagent (Tropix, Bedford MA,
USA) and Fuji Super RX-film (FujiFilm Corporation, Tokyo, Japan).
2.4 Results
2.4.1 Nup153 interacts with both A- and B-type lamins in vitro
In previous reports it was demonstrated by blot overlay assays that residues 896-1475 of
human Nup153 are binding exclusively to the Xenopus lamin LIII, but not to lamin A or
emerin (Smythe et al., 2000). Immunoprecipitation of Nup153 from rabbit reticulocyte
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lysate, however, co-precipitated both lamin B and lamin A (Smythe et al., 2000). To over-
come these discrepancies, we performed solution-binding assays to more specifically anal-
yse the interaction between Nup153 and nuclear lamins. To do so, we expressed distinct
Nup153 fragments recombinantly in E.coli and human A- and B-type lamins by coupled
in vitro transcription/translation using the rabbit reticulocyte lysate system. Recombinant
GST-Nup153 fusion proteins were purified, immobilised on glutathione-sepharose beads
and incubated with 35S-labelled lamin. After incubation, bound and unbound protein frac-
tions were analysed by SDS-PAGE. As shown in Figure 2.1A, GST-fusions of full-length
human Nup153 (GST-Nup153), a N-terminal fragment expressing residues 2-339 (GST-
N339), and a C-terminal fragment of Xenopus Nup153 (residues 1001-1382; GST-C1) bind
to pre-lamin A (pre-LA), mature lamin A (LA) as well as lamin B1 (LB1). No binding of pre-
LA, LA or LB1 was observed to GST alone, despite some non-specific background binding.
To more precisely determine which domain of the lamins mediates the interaction with
Nup153, we next produced the tail domains of lamin A and C (LAT and LCT, respectively)
by coupled in vitro transcription/translation and analysed their ability to bind to our GST-
Nup153 fusion proteins. As shown in Figure 2.1B, all Nup153 fragments bind to both LAT
and LCT. Together these data indicate that the N-terminal as well as the C-terminal domain
of Nup153 exhibits binding sites for the tail domain of both A- and B-type lamins.
2.4.2 Nup153 interacts with the Ig-fold of A- and B-type lamins
To further dissect the interactions of Nup153 with the tail domain of lamins, we examined
the Ig-fold domain of the nuclear lamins for their potential to bind Nup153. The Ig-fold
is embedded in the tail domain of lamins and is known to be involved in protein-protein
interactions (Dechat et al., 2008). We employed 35S-lamin fragments comprising the Ig-
fold of lamins A, B1 and B2, respectively, and carried out solution binding assays using
GST-Nup153 fusion proteins as described above. As shown in Figure 2.1C, the Ig-folds of
LA, LB1 and LB2 bind to GST-Nup153, GST-N339 and GST-C1 fusion proteins, but not to
GST alone, indicating that Nup153 specifically interacts with the Ig-fold of A- and B-type




Figure 2.1: Nup153 binds directly with the Ig-fold of A- and B-type lamins in vitro - So-
lution binding assays were carried out using recombinant GST-Nup153 fragments comprising
the full-length protein (GST-Nup153), a fragment of the N-terminal domain of human Nup153
(residues 2-339; GST-N339), a C-terminal domain fragment (residues 1001-1382 of Xenopus
Nup153; GST-C1) and/or GST alone expressed in E.coli. Lamin fragments corresponding to
(A) pre lamin A (pre-LA), mature lamin A (i.e. after cleavage of 18 amino acid residues at
the end of the C-terminal domain; (LA)) and full length lamin B1 (LB1), (B) to the tail do-
main fragments corresponding to lamin A tail (LAT), lamin C tail (LCT), and (C) to the Ig-fold
of lamin A (LA-Ig), lamin B1 (LB1-Ig), lamin B2 (LB2-Ig) were labelled with 35S-methionine
by coupled in vitro transcription and translation (see Experimental Procedures). GST-Nup153
fragments were immobilised on glutathione sepharose beads, incubated in solution with 35S-




Figure 2.2: Nup153 binds to Xenopus LIII - Solution binding assays were carried out as
summarised in Figure 2.1. GST-Nup153 fragments corresponding to the full length (Nup153),
the N-terminal domain (N339), C-terminal domain (C1), or GST alone were expressed in
E.coli. Purified fragments incubated with Xenopus LIII fragments labelled with 35S-methionine
by coupled transcription and translation (see Section 2.3) corresponding to the full length
(LIII), the tail domain (LIII-T), the Ig-fold (LIII-Ig). GST-Nup153 fragments were immobilised
with glutathione sepharose beads and then incubated in solution with 35S-lamin fragments
and unbound (U) and bound (B) fractions were eluted by the addition of sample buffer and
resolved by SDS-PAGE and autoradiography.
2.4.3 The N-terminal and C-terminal domains of Nup153 form distinct com-
plexes with nuclear lamins
Nup153 interacts with importin-β via its C-terminal FG-repeat domain (Moroianu et al.,
1995; Shah et al., 1998) and lamins in turn are thought to be imported via the importin-
α/β pathway (Adam et al., 2008; Loewinger and McKeon, 1988). The observed complexes
between Nup153 and the lamins might therefore resemble a nuclear import complex that
eventually would include importin-α and -β . Therefore we next analysed the association
of importin-β with the Nup153-lamin complexes. To do so, the bound fractions of our
solution binding assays were loaded onto SDS-PAGE, transferred to a PVDF membrane
and probed with anti-importin-β antibodies. We found that importin-β is present in the
complexes of the C-terminal domain of Nup153 with lamin A and lamin B, but is absent
from complexes between lamins and the N-terminal domain of Nup153 (Figure 2.3A).
These data indicate that the N-terminal domain of Nup153 binds directly to both A- and
B-type lamins, whereas complexes between the C-terminal domain of Nup153 and lamins
are at least heterotrimeric. Thereafter we analysed whether the heterotrimeric complex
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of the C-terminal fragment of Nup153, lamins and importin-β resembles a nuclear im-
port complex. If so, the complex would (i) depend on the presence of a NLS in lamin,
(ii) contain importin-α that typically mediates the interaction between the cargo (i.e.
lamin) and importin-β , and (iii) become dissociated by RanGTP. Alternatively, Nup153
may bind to lamin and importin β simultaneously via its FG-repeat domain. To distin-
guish between the two possibilities, we first performed solution-binding assays with the
C-terminal domain of Nup153 and the Ig-fold of lamins A and B1. The Ig-fold is lacking
the NLS and is therefore not able to bind to an importin-α/β complex. While importin-α
and -β are detectable in the reticulocyte lysate (control), importin-β , but not importin-
α, co-assembled with the complexes of Nup153-C and the Ig-fold of lamin A and lamin
B1, respectively (Figure 2.3B). This indicates that importin-β is binding to the FG-repeats
of Nup153 and not to either of the lamins, mediates by importin-α as part of an import
complex. Similarly, importin-α is absent from complexes of Nup153-C with full-length LA
or LB1 (data not shown). To confirm the validity of the results, we asked whether the
heterotrimeric Nup153-C-lamin-importin-β complex gets dissociated in the presence of
RanGTP. Complexes between importin-α/β and their cargo are dissociated by the binding
of RanGTP to importin-β , resulting in decreased affinity of importin-α to the NLS (Kobe,
1999). We therefore employed RanQ69L-GTP, a constitutively active Ran mutant (Palacios
et al., 1996), to our solution binding assay. As shown in Figure 2.3C, excess amount of
RanQ69L-GTP did neither release the complex between the N-terminal or the C-terminal
domain of Nup153 and lamins (Figure 2.3C). This provides further evidence that the com-
plex between the C-terminal domain of Nup153 and the nuclear lamins does not resemble
a nuclear protein import complex (see also (Smythe et al., 2000)). Together our data in-
dicate that the C-terminal domain of Nup153, despite the presence of importin-β , is able
to directly interact with the Ig-fold of A- and B-type lamins, analogue to the N-terminal
domain.
2.4.4 Nup153 co-immunoprecipitated lamin A and lamin B from HeLa cell
extracts
To validate our in vitro data, we examined whether Nup153 and lamins can be co-immuno-
precipitated from HeLa cell extracts. To precipitate Nup153, a monoclonal antibody against
the N-terminus (7A8; IP Nup153-N) or the C-terminus (SA1; IP Nup153-C) of human
Nup153 were used. Immunoprecipitates were analysed for the presence of nuclear lamins
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Figure 2.3: Nup153 association with lamins is not part of an import complex - (A) So-
lution binding assays were carried out using GST-Nup153 fragments corresponding to the N-
terminal domain (GST-N339) or the C-terminal fragment of the Xenopus Nup153 (GST-C1)
expressed in E.coli. 35S-lamin fragments produced in vitro by transcription and translation
(see Section 2.3) corresponding to pre-LA, LB1 and Xenopus LIII. GST-Nup153 fragments were
immobilised on glutathione sepharose beads, incubated in solution with 35S-lamin fragments
and unbound and bound fractions were resolved by SDS-PAGE and immunoblotted with an
antibody that recognises human importin-β . Importin-β is co-assembling with the complex
between Nup153-C and lamin Ig-folds, but not with the complex of Nup153-N and lamins. (B)
Importin-α is not detectable in the complex between Nup153-C and the nuclear lamins. (C)
RanQ69L-GTP does not dissociate the Nup153-C-lamin complex. 35S-lamin fragments were
first incubated with 20 µg RanQ69L-GTP for 10 min at 37 ◦C prior to solution binding assay,
then incubated with GST-Nup153 fragments, immobilised on glutathione sepharose beads, and
unbound (U) and bound fractions (B) resolved by SDS-PAGE and subjected to autoradiography.
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Figure 2.4: Co-immunoprecipitation of Nup153 and nuclear lamins from HeLa extracts
- (A) Total HeLa extracts were immunoprecipitated using anti-Nup153 antibodies that recog-
nises the C-terminal domain (SA1; Nup153-C) or the N-terminal domain of Nup153 (7A8;
Nup153-N). Equivalent amounts of HeLa extracts (L), immune supernatants (S) and immune
precipitate (P) were separated by SDS-PAGE and analysed by immunoblotting using anti-lamin
A (LA), Xenopus (xLB1) or human (LB1) lamin B1 and lamin B2 (LB2) antibodies. (B) Im-
munoblotting using anti-Nup153 verified co-precipitation with lamin A.
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Figure 2.5: Nup153 binding to the Ig-fold of lamin A and lamin B1 requires distinct
residues - (A) Solution binding assays were carried out using recombinant GST-Nup153 frag-
ments comprising truncations of its N-terminal domain between residues 2-339, i.e. GST-
N(2-144), GST-N(39-110), GST-N(39-144), GST-N(87-144), GST-N(145-339), GST-N(39-339)
and GST alone expressed in E.coli as and lamin fragments comprising the Ig-fold of lamin A
(LA-Ig) and lamin B1 (LB1-Ig) labelled with 35S-methionine by coupled in vitro transcription
and translation (see Section 2.3). GST-Nup153 fragments were immobilised on glutathione
sepharose beads, incubated with lamin fragments, and unbound (U) and bound (B) fractions
eluted by the addition of sample buffer and resolved by SDS-PAGE and autoradiography. (B)
Schematic representation of the residues between 2-339 of human Nup153 that are required
for a sufficient binding to the lamin A and the lamin B1 Ig-fold, respectively. +++, strongest
binding; ++ strong binding; +, moderate binding; -, no binding.
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by immunoblotting and we found that both antibodies against Nup153 co-precipitated
lamin A, B1 and B2 (Figure 2.4A). Using the same procedure, antibodies raised against
both human and Xenopus lamin A were found to co-precipitate Nup153 (Figure 2.4B),
whereas lamin B1 and B2 did not co-immunoprecipitated Nup153, most likely due to the
low solubility of B-type lamins. Taken together, our data show that Nup153 is bound to
lamin A and lamin B in HeLa cell extracts.
2.4.5 Binding of the Ig-fold of lamins occurs at a specific region at the N-
terminal domain of Nup153
We next aimed to further define the interaction between the N-terminal domain of Nup153
and the Ig-fold. To do so, we employed smaller fragments of the N-terminal domain
of Nup153, specifically residues 2-339 (GST-N339; Figure 2.1C), to map the amino acid
residues involved in the interaction site with the lamin Ig-folds. Nup153-fragments fused
to GST comprising residues 2-144, 39-110, 39-144, 87-144, 145-339, and 39-339, respec-
tively, were expressed in E.coli, immobilised on glutathione sepharose, and incubated with
Ig-fold of lamin A and lamin B1 produced by coupled in vitro transcription and transla-
tion. Unbound (U) and bound (B) fractions were resolved by SDS-PAGE and subjected
to autoradiography. We found that the lamin A Ig- fold bind to all Nup153 N-terminal
truncations with strongest binding to residues 39-339 (GST-N(39-339); Figure 2.5A and
2.5B), and weakest binding to residues 39-110 (GST-N(39-110); Figure 2.5A and 2.5B).
We conclude that multiple residues are contributing to the association of the N-terminus
of Nup153 with the Ig-fold to nuclear lamins. The Ig-fold of lamin B1 as well binds to the
N-terminal domain of Nup153 within residues 2-339 (Figure 2.1C), however in contrast
to lamin A it did not interact with any of the above listed shorter fragments of Nup153
(Figure 2.5A). This demonstrates that residues 2-39 of human Nup153 are critical but not
sufficient for binding of Nup153 to the Ig-fold of lamin B1.
2.5 Discussion
Previous studies have shown that Nup153 interacts with lamin B while the exact binding
specificity had remained unclear. Here we further investigated the binding of Nup153
with lamins and characterised the domains that are involved in this interaction. Our data
demonstrate that both the N- and the -C terminal domains of Nup153 bind to the Ig-fold
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of A- and B-type lamins. The association of lamins with Nup153 appears to be direct,
notwithstanding the presence of importin-β in complexes of the C-terminal domain of
Nup153 and the Ig-fold of lamins. A closer examination of the interface between the N-
terminal domain of Nup153 and the Ig-fold of lamin B1 revealed that residues 2-339 are
essential for binding. In contrast, the lamin A Ig-fold exhibits multiple interaction sites
within residues 39-339 of Nup153, i.e. the NPC association region (Bastos et al., 1996b;
Enarson et al., 1998). These different binding premises indicate functional differences of
the complexes between Nup153 and A- and B-type lamins, respectively.
The existence of distinct complexes between Nup153 and nuclear lamins can be ex-
plained by (i) the domain topology of Nup153 in the NPC and (ii) the multiple functions
associated with both Nup153 and the nuclear lamins. Nup153 resides at the nuclear bas-
ket of the NPC with the N-terminal domain localising to the nuclear ring moiety of the
basket (Fahrenkrog et al., 2002; Pante et al., 2000; Walther et al., 2001). The nuclear
ring moiety is in close proximity to the inner side of the NE where the majority of the nu-
clear lamins reside. Nup153 recruitment to the NE and NPCs depends on an intact nuclear
lamina (Smythe et al., 2000) and it is required for an even distribution of NPCs in the NE
(Walther et al., 2001). Lamins on the other hand are also critical for NPC positioning in
the NE, indicating that an interaction between Nup153 and the lamins is important to hold
NPCs in place. Given the close proximity of the N-terminal domain of Nup153 and the
nuclear lamina it is most likely the complex between the N-terminus of Nup153 and the
Ig-fold of nuclear lamins functions in order to maintain a stable NE architecture.
The C-terminal domain of Nup153 contains multiple FG-repeats, which resemble na-
tively unfolded structures that are mainly involved in nucleocytoplasmic transport (Shah et
al., 1998). Nup153 is known to have high affinity binding site for importin-β (Ben-Efraim
and Gerace, 2001) and lamins are in turn thought to be imported into the nucleus by
an importin-α/β -dependent manner (Adam et al., 2008; Loewinger and McKeon, 1988),
which implicated that the complex between Nup153 and the nuclear lamins may reflect
the presence of both proteins in an import complex. Several lines of evidence presented
here suggest that this is not the case. First, in solution binding assays importin-β was
detected in complexes between the C-terminal domain of Nup153 and the nuclear lamins,
but not so importin-α (Figure 2.3A and 2.3B). Secondly, Nup153 and the nuclear lamins
remained associated in the presence of RanQ69L-GTP, which typically dissociates nuclear
import complexes. Third, Nup153 associates with the Ig-fold of A-and B-type lamins, while
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the NLS of lamins is located a few residues upstream of the Ig-fold. Together these data
suggest that the observed association between the C-terminal domain of Nup153 and the
nuclear lamins is functionally different a nuclear import complex, consistent with previous
findings (Smythe et al., 2000).
Our data demonstrate that both the N-terminal and the C-terminal domain of Nup153
interact with the nuclear lamins. This gives rise to the question, whether two different
complexes exist. Further studies are required to fully resolve this question, but two sce-
narios are plausible. The C-terminal domain of Nup153 is highly flexible and can shuffle
between the nucleoplasmic and the cytoplasmic face of the NPC (Fahrenkrog et al., 2002;
Paulillo et al., 2005). Therefore it is conceivable that the C-terminus of Nup153 folds back
onto an intermediate complex between Nup153 and the respective lamin at the NE. This
could help stabilising the complex and/or regulating the accessibility of both proteins for
other binding partner. Alternatively, multiple populations of Nup153 may exist in the NPC
or the nucleoplasm (Griffis et al., 2004), which may include different complexes between
Nup153 and nuclear lamins. This is in particular interesting, as lamin A, but not lamin B,
is present in a minor soluble pool within the nucleoplasm, which has been shown to par-
ticipate in various nuclear processes (Dorner et al., 2007). It remains to be seen if Nup153
is able to associate with this soluble lamin A pool. The existence of multiple Nup153-lamin
complexes with differing functions is further supported by our finding that lamin A binds
to different sites within the N-terminal domain of Nup153 than lamin B. The Ig-fold of
lamin A displayed multiple binding within residues 39-339 of human Nup153, while the
lamin B1-Ig fold did not bind to fragments shorter than residues 2-339 (Figure 2.5, A and
B).
As a summary, our data provide evidence for a complex interplay between Nup153
and A-type as well as B-type lamins, which appears far more sophisticated than previously
assumed. Future studies will be required to expand our current understanding of the
interactions of Nup153 with nuclear lamins, in particular regarding their importance in the
context of lamin A-associated disease, the so-called laminopathies. Previous studies have
indicated that Nup153 co-aggregated with lamin A in the presence of lamin A mutation
causing HGPS, which led to clustering of NPCs (Goldman et al., 2004; Hubner et al.,
2006b). Moreover, in particular the N-terminal domain of Nup153 was detected in some of
these aggregations (Hubner et al., 2006a). Hence, more studies will be needed to examine
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the role of Nup153 interactions with nuclear lamins in disease associated mutations of
lamin A.
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Recently, we showed that the Ig-fold of A-, and B-type lamins interacts directly with the
nucleoporin Nup153 and we mapped multiple binding sites within residues 39 to 339 of
the N-terminal domain of Nup153 (Nup153-N) that are required for the interaction. Here,
we further analysed the effect of altered expression of either lamin A or B on Nup153
binding and localisation. We carried out solution binding assays, immunofluorescence
microscopy and co-immunoprecipitation. Our in vitro binding assays revealed that the in-
teraction between Nup153 and lamin A is altered when two point mutations, R453W and
R482W, respectively, were introduced into the Ig-fold of lamin A. Furthermore, a deletion
of 50 residues at the C-terminal end of lamin A tail domain (LA∆50) did not interfere
with binding in vitro. Furthermore, Nup153 localisation depicts normal punctuated stain-
ing at the nuclear rim and more overlapping with nucleoplasmic lamin A in HeLa cells
expressing wild-type or R453W and is not recruited into R482W intranuclear foci. Faint
or lack of Nup153 staining is seen in perturbed cells expressing LA∆50. Furthermore,
Nup153 co-aggregates with lamin B in HeLa cells transiently expressing B-type lamin-GFP
fusion constructs, but not with a mutant of lamin B1. Conversely, lamins are not recruited
to Nup153 aggregates in cells expressing GFP-Nup153. Furthermore, GFP antibodies co-
precipitate more Nup153 from HeLa cells transfected with GFP-lamin A and the R453W
mutant than with the R482W or LA∆50 mutants. Our results suggest distinct mutations
in lamin can manipulate Nup153 binding to a certain extent, the degree of which can be
related to the severity of the mutation-linked diseases.
3.2 Introduction
Nuclear lamins are the main components of the nuclear lamina; a filamentous meshwork
residing at the nuclear periphery of the inner nuclear membrane (INM) of the nuclear en-
velope (NE) of vertebrate cells (Aebi et al., 1986). Lamins belong to type V intermediate
filament proteins (IFs), and similar to all IFs, the lamin molecule has a tripartite structure
with a large α-helical coiled coil rod domain flanked by two non-helical N- and C-terminal
domains (Fisher et al., 1986). The rod domain contains an additional 42 residues not
found in the cytoplasmic IFs of vertebrates (Monteiro et al., 1994). Compared to cyto-
plasmic IFs, the C-terminal domain of lamins contains three unique features; an nuclear
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localization signal (NLS) for nuclear targeting, an Ig-fold like motif which is highly con-
served among lamins and engaged in protein and chromatin interactions, and a CAAX-box,
which undergoes post-translational modifications and constitutes a site for the addition
of a farnesyl lipid group (Heitlinger et al., 1992; Mical and Monteiro, 1998; Ralle et al.,
2004). In mammalian cells, lamins are divided into two groups; A-type and B-type lamins
(Schirmer and Gerace, 2004). A-type lamins are encoded by a single gene LMNA, which
by alternative splicing, gives rise to two major A-type lamins in somatic cells; lamin A and
lamin C, respectively (Burke and Stewart, 2006). B-type lamins are encoded by two in-
dividual genes LMNB1 and LMNB2 giving rise to lamin B1 and lamin B2, respectively in
somatic cells (Stuurman et al., 1998; Vorburger et al., 1989). While B-type lamins are
ubiquitously expressed in all cell types, A-type lamins are only found in differentiated cells
(Gerace and Burke, 1988). Biochemically, B-type lamins are permanently farnesylated at
the CAAX domain, whereas, lamin A is only transiently farnesylated and loses its farne-
syl characteristic once incorporated into the nuclear lamina (Mical and Monteiro, 1998;
Rusinol and Sinensky, 2006). Nuclear lamins are implicated in nucleus-related functions
including maintaining nuclear architecture, ordering the spacing between nuclear pore
complexes (NPCs), regulating transcription, controlling differentiation and chromatin or-
ganisation (Dechat et al., 2008; Mattout et al., 2006; Shimi et al., 2008). Consequently,
dysfunction of lamins is often associated with human diseases. To date, more than 200
mutations have been identified in LMNA, which cause heterogeneous disorders, termed
laminopathies (Gruenbaum et al., 2005; Stewart et al., 2007; Worman and Bonne, 2007).
Laminopathies can either affect striated muscle, such as in autosomal dominant Emery-
Dreifuss muscular dystrophy (AD-EDMD), dilated cardiomypathy (DCM), and limb girdle
muscular dystrophy (LMG1B) (Bonne et al., 1999). Or they can affect adipose tissue, such
as in Dunnigan-type familial partial lipodystrophy (FPLD) and mandibuloacral dysplasia
(MAD) (Mounkes et al., 2003). Moreover, mutation in LMNA can lead to premature aging
syndromes, such as Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner’s
syndrome (Eriksson et al., 2003). In contrast, mutations in LMNB are thought to be em-
bryonic lethal and only two mutations in LMNB2 were identified recently in patients with
acquired partial lipodystrophy (APL) (Capanni et al., 2003), as well as duplications in
LMNB1 which result in autosomal dominant leukodystrophy (ADLD) (Capell and Collins,
2006; Hegele et al., 2006; Padiath et al., 2006). More than 20% of the LMNA mutations
are allocated to the Ig-fold in the tail domain. Two such mutations by which an arginine
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(R) is mutated to a tryptophan (W) at codons 453 and 482, result in AD-EDMD and FPLD,
respectively (Cao and Hegele, 2000; Speckman et al., 2000). R453 resides at the core of a
β -sheet of the Ig-fold where it is involved in a salt bridge formation, whereas residue R482
resides at the core of the Ig-fold. When mutated, R453 destabilised the overall structure
of the C-terminal domain of the lamin molecule, while R482 mutation affect binding sites
to lamin A-binding proteins (Dhe-Paganon et al., 2002; Krimm et al., 2002). The most
frequent mutation resulting in HGPS is a de novo C to T substitution at position 1824 of
LMNA, which results in a protein that lacks 50 amino acids at the C-terminal domain, called
LA∆50 or progerin. Progerin is permanently farnesylated and irreversibly anchored to the
nuclear membrane, thereby disrupting normal lamin function and localisation (Scaffidi
and Misteli, 2005) (Amati et al., 2004; D’Apice et al., 2004; Eriksson et al., 2003). Within
the NE, lamins interact with nuclear pore complexes (NPCs) that mediate the passage of
molecules in and out of the nucleus. NPCs are made up of multiple copies of 30 different
proteins, termed nucleoporins, one of which is Nup153. Nup153 is a highly dynamic glyco-
protein comprised three distinct domains; an N-terminal domain (residues 1-610) required
for its incorporation into the NPC and the NE stationary (Bastos et al., 1996; Enarson et al.,
1998; Nakielny et al., 1999), a central zinc-finger domain (residues 650-880) as well as
a C-terminal domain (residues 881-1475) implicated in nucleocytoplasmic transport (Ball
and Ullman, 2005). Nup153 is long known to bind to B-type lamins (Smythe et al., 2000),
and that Nup153 distribution is often affected in cells expressing lamin mutations (Bechert
et al., 2003; Goldman et al., 2004; Hubner et al., 2006a; Matitioli et al., 2008; Morris,
2001; Muchir et al., 2003; Pan et al., 2007; Raharjo et al., 2001; Sagelius et al., 2008a;
Sagelius et al., 2008b; Shackleton et al., 2000; Sullivan et al., 1999). We have previously
showed that Nup153 exhibits binding sites for the Ig-fold of A- and B-type lamins in its N-
and C-terminal domain (Al-Haboubi et al., submitted). Here we analysed the effect of al-
teration in lamin A and lamin B1, respectively, on the interaction with Nup153 by means of
biochemistry, immunofluorescence microscopy and co-immunoprecipitation. Our in vitro
binding assays reveal that mutations in the Ig-fold causing AD-EDMD and FPLD disrupt
binding specificity of lamin A to Nup153. Immunoprecipitation assays further supported
this in vitro data. Furthermore, we show that Nup153 is co-localising with lamin A in cells
expressing wild-type and AD-EDMD mutation, but it its localisation is not affected in FPLD
expressing cells. Furthermore, Nup153 is re-distributed in cells expressing lamin A carry-
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ing HGPS mutation. Our findings suggest that mutation specific defects in lamin-Nup153
interactions associated with lamin related diseases.
3.3 Experimental Procedures
All experimental procedures were carried out at room temperature, unless otherwise stated.
3.3.1 DNA constructs
a) Lamin expression constructs and mutagenesis pEGFP-lamin A, pEGFP-lamin B1 and
pET-lamin III were obtained from R.D. Goldman (Northwestern University, Chicago) and
pEYFP-lamin B2, pET-lamin A/del ta50 and pEGFP-lamin A∆50 were generous gift of H
Harald Herrmann (German Cancer Research Center, DKFZ, Heidelberg). pcDNA-lamin
A-Ig (Ilona Huegi, former MSc-student). Site directed mutagenesis were carried out fol-
lowing manufacturer’s protocol for single amino acid substitution using Pfu Ultra HF; High
fidelity DNA polymerase (Stratagene, La Jolla CA, USA). A single amino acid from lysine
(R) to a tryptophane (W) i) R453W in pEGFP-lamin A and pcDNA-Lamin A Ig using the fol-
lowing primers (5’-GAG GGC AAG TTT GTC TGG CTG CGC AAC AAC TCC-3’ and 3’-GGA
GTT GTT GCG CAG CCA GAC AAA CTT GCC CTC-5’) ii) R482W in pEGFP-Human lamin A
and pcDNA-Lamin A Ig using the following primers (5’-CCC TTG CTG ACT TAC TGG TTC
CCA CCA AAG TTC-3’ and 3’-GAA CTT TGG TGG GAA CCA GTA AGT CAG CAA GGG-5’) iii)
CAIM to SAIM; A cysteine (C) change to serine (S) in pEGFP-Lamin B1, using the following
primers (5’-TCC AAT AGA AGC TCA GCA ATT ATG TAA TCT AGA G-3’ and 3’-CTC TAG ATT
ACA TAA TTG CTG AGC TTC TAT TGG A-5’). b) Nup153 expression constructs pGEX-4T-
HA-Nup153-His and pGEX 4T-HA-Nup153-N (residues 3-600) are as described previously
(Al-Haboubi et al., submitted). pGEX-6P-C-hNup153 (residues 874-1475) was previously
described (Lim et al., 2006), pGEX-C1-Nup153 (Xenopus residues 1001-1385) and pET-
C2-Nup153 (Xenopus residues 1375-1603), were obtained from Katie Ullman (Fahrenkrog
et al., 2002).
3.3.2 Cell culture and transfection
HeLa cells were maintained in Dulbecco’s modified Eagle medium (Gibco/Invitrogen, Life
Technologies Corporation, CA), supplemented with 10% FBS (PAA), 100-units/ml peni-
cillin/ 100 µg/ml streptomycin (Gibco/Invitrogen) and 2 mM glutamine (Gibco/Invitrogen).
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HeLa cells were grown in a monolayer in a humidified 37 ◦C incubator supplied with 5%
CO2. Cells seeded in either 6- or 24-well plates one day prior to transfection 30% den-
sity. Cells were transiently transfected using either TurboFect (Fermentas Life Sciences, St.
Leon-Rot, Germany) or Lipofectamine2000 (Invitrogen Life Sciences, CA), following man-
ufacturer’s protocol. Briefly 1 µg of DNA and 2 µl of transfection reagent were used and
cells were incubated for 24-48 hours.
3.3.3 Immunofluorescence microscopy
HeLa cells grown on glass coverslips were fixed and stained as described earlier (Spector
and Smith, 1986). Briefly, cells were fixed in 2% paraformaldehyde for 15 min, followed by
three steps of washing in 1xPBS with 5 min intervals. Fixed cells were permeabilised in PBS
containing 0.2% Triton X-100 and 1% BSA for 10 min on ice. Cells were then washed three
times in PBS containing 1% BSA and incubated with primary and secondary antibodies for
1 hr, respectively. After washing 3 times in PBS, cells were mounted on glass slides using
Mowiol. The nuclei were stained with blue-fluorescent DAPI. Images were recorded on a
Leica TCS SP5 microscope (Leica Microsystems CMS GmbH, Mannheim, Germany) using
100x or 63x oil objectives and processed using the Leica imaging software, ImageJ 1.41o
and Adobe Photoshop CS4.
3.3.4 Antibodies
The following antibodies were used in Western blot analysis and immunofluorescence la-
belling, respectively. Mouse monoclonal SA1 (1:50 dilution; a gift of Brian Burke, Univer-
sity of Calgary, Calgary, Alberta, Canada, (Bodoor et al., 1999)) against the C-terminus of
human Nup153. Rabbit polyclonal anti-lamin B1 (ab16048; 1:3000; Abcam, Cambridge,
MA, USA) recognises an epitope within residues 400-500. A rabbit polyclonal (no. 324, gift
of R.D. Goldman, (Dechat et al., 2007)) against human lamin A peptide cVTVTRSYRSVG-
GSG, which corresponds to residues 620-633; (1:1000). A rabbit polyclonal human lamin
B2 antibody (no. 328, gift of R.D. Goldman) against a specific peptide cTVKKSSVM-
RENENG, which corresponds to residues 576-589 (1:1000). All secondary antibodies
for immunoblotting coupled to alkaline phosphatase were obtained from Sigma-Aldrich.
A monoclonal antibody, mAb414 recognises FG repeat-containing Nups, predominantly
Nup62 but also Nup153 (Davis and Blobel, 1986). Two mouse monoclonal GFP antibodies
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(1:1000, MAB0043, Dianova GmbH, Heidelberg, Germany), and (118144600001, 1:1000,
Roche Diagnostics, Indianapolis IN, USA) were used in immunoprecipitation assays. Indi-
rect immunofluorescence was visualized using red-orangeÐfluorescent Alexa Fluor® 568
goat antiÐmouse IgG antibody (A11004, Invitrogen Molecular Probes, CA) and far-red-
fluorescent Alexa Fluor® 647 goat anti rabbit IgG (A21245, Invitrogen Molecular Probes,
CA).
3.3.5 Recombinant protein expression and purification of glutathione S-transferase
(GST) coupled Nup153 fragments
GST-fusion proteins of Nup153 were expressed in E.coli BL21-DE3 codon (+) cells. A 5ml
over night culture was used to inoculate 1-3 litres of LB medium and grown at 37 ◦C until
an optical density at 600 nm of 0.6 was reached. Protein expression was next induced
by the addition of 0.1 mM IPTG and cells were grown in culture for 3 hours at 37 ◦C and
shaking at 180 rpm. Bacterial pellets were collected by centrifugation at 5000 rpm for 10
min at 4 ◦C (SLA3000, Sorvall). The pellet was resuspended in phosphate buffered saline
(PBS) containing 0.5 mM PMSF, 5.0 µg/ml aprotinin and 5.0 µg/ml leupeptin, lysed by
sonication and cleared centrifugation at 20,000 g for 45 min at 4 ◦C. The supernatant
was next incubated with glutathione sepharose-4B (GE Healthcare Biosciences, Uppsala,
Sweden) for 2 hours while shaking, transferred onto a poly-prep chromatography column
(Bio-Rad laboratories, CA), washed by the addition of PBS (binding buffer) 3-4 volumes
and eluted using elution buffer (20 mM glutathione (reduced form, AppliChem, Darmstadt,
Germany), 100 mM Tris pH 8.0, 120 mM NaCl, 10 mM DDT). In a second purification
step, proteins were loaded on a nickel column (Ni-NTA agarose, Qiagen GmbH, Hilden,
Germany), washed and eluted using 500 mM Imidazole, collected fractions were dialysed
against PBS and stored in aliquots at -80 ◦C.
3.3.6 Coupled in vitro transcription and translation
Coupled in vitro transcription and translation of proteins was performed using the TNT®
quick- translation system kit (Promega, Madison, WI, USA) following the manufacturer’s
protocol. In brief, 40 µl of quick master mix were incubated with 2 µg of plasmid DNA,
1-2 µg/µl of aprotinin and leupeptin, and 4 µl of [35S]-methionine (either L-Methionine
500 µCi; GE-Amersham Biosciences, Buckinghamshire, UK, or Easytag Methionine-[35S];
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Perkin Elmer Life Sciences, Boston MA, USA) at 30 ◦C for 90 min. 1µl of RNase inhibitor
(RNasin N251A; Promega, Madison WI, USA) was added just 5 min prior to terminating
the reaction, as specified by the manufacturer’s protocol. 5 µl of product was mixed with
10 µl of 3x sample buffer and boiled at 95 ◦C for 10 min and then separated by SDS page
followed by autoradiography.
3.3.7 Blot overlay assays
His-tagged lamin fragments were expressed and purified as previously described (Shu-
maker et al., 2005). Equal amount of lamin fragments were then resolved by SDS-PAGE,
transferred onto a PVDF membrane and blocked for 1 hr in PBS containing 0.1% Tween-20
and 5% milk. Next, the membranes were incubated at 4 ◦C overnight with [35S]-Nup153
fragments produced using a coupled transcription and translation system, washed in PBS
containing 0.1% Tween-20, air-dried and subjected to autoradiography.
3.3.8 Solution binding assays
Solution binding assays were performed as previously described (Walter et al., 2006).
3.3.9 Immunoprecipitation assays
HeLa cell extracts were prepared from cultured cells grown in 6-well plates (approximately
95% confluence) post transfection with GFP-coupled lamin constructs. Cells were lysed in
500 µl ice-cold RIPA buffer (sc-24948, Santa Cruz Biotechnology) and homogenised with
20 strokes in a Dounce homogeniser. The lysate was then centrifuged at full speed using a
tabletop centrifuge for 30 min. Next, the supernatant was pre-cleared by incubating with
20 µl of pre-equilibrated protein A-agarose (sc-2001, SantaCruz Biotechnology) for 1 hour
at 4 ◦C rotating and the supernatant was subsequently incubated with 1µg of GFP-antibody
and rotated for 2 hr at 4 ◦C. To immobilise the antibody, the mixture was incubated with
60 µl of protein A-agarose and rotating at 4 ◦C for 2 hours. The beads were washed 3-4
times with lysis buffer and 30 µl of 3x sample buffer was added to beads and boiled while
mixing at the same time to elute bound fractions.
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3.3.10 SDS-PAGE and immunoblotting
Protein samples were resolved by SDS-PAGE and either stained with Coomassie blue or
transferred to PVDF membrane and probed with the appropriate antibodies and developed
using the Western Lighting CDP-Star® Chemiluminescence Reagent (Tropix, Bedford MA,
USA) and Fuji Super RX-film (FujiFilm Corporation, Tokyo, Japan).
3.4 Results
3.4.1 Binding of Nup153 with the Ig-fold is diminished in the presence of
EDMD-causing mutant R453W in vitro
By solution binding assays we have recently shown Nup153 interacts with the Ig-fold of
lamins A, B1, B2 and Xenopus LIII (Al-Haboubi et al., submitted). To further analyse
the interaction between Nup153 and the Ig-fold of lamins we introduced a mutation in
the Ig-fold of lamin LIII and carried out blot-overlay assays. We mutated R454 to W
by site-directed mutagenesis (Shumaker et al., 2005). The corresponding mutation in
lamin A (R453W) is associated with EDMD (Krimm et al., 2002). We employed [35S]-
methionine labelled Nup153 fragments corresponding to the full N-terminal domain (35S-
hNup153N), residues 2-339 N339 (35S-hNup153N339), and one fragment corresponding
to the C-terminal domain of Xenopus Nup153 ((35S-xNup153C), residues 1375-1603)).
Equal amounts of full-length human lamin A, Xenopus LIII, LIII-Ig, and LIII-IgR454W frag-
ments were separated by SDS-PAGE 3.1A, blotted on a PVDF membrane and incubated
overnight at 4 ◦C with 35S-Nup153 fragments. The membrane was then air-dried and sub-
jected to autoradiography. Consistent with our previous studies (Al-Haboubi et al., sub-
mitted), we observed binding of full-length Nup153 to LA and to LIII (see Figure 3.1B).
This interaction appears enhanced to the Ig-fold of LIII, but is weakened in the R454W
mutant 3.1B. Similarly, the N-terminal domain of Nup153 binds to LA, LIII and enhanced
to the Ig-fold with of LIII 3.1C. This interaction of the Ig-fold with Nup153-N was not af-
fected by the R454W mutation 3.1C, in contrast to full-length Nup153. The C-terminal
domain of Nup153, as shown in Figure 3.1D, binds to hLA and even stronger to LIII and
the LIII-Ig-fold, whereas the interaction appears lost in the presence of the R454W muta-
tion. Together these data indicate different binding sites of the N-terminal and C-terminal
domain of Nup153 for the Ig-fold of nuclear lamins.
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Figure 3.1: Nup153 binds weaker to the Ig-fold carrying the AD-EDMD mutation R453W
- Blot overlay assays were carried out as described in Experimental Procedure. (A) Full-length
human lamin A, full-length Xenopus LIII, the LIII Ig-fold (LIII-Ig), and the Ig-fold carrying AD-
EDMD mutation R454W (LIII-IgR454W) fragments were separated by SDS-PAGE and incu-
bated with 35S-Nup153 fragments produced by in vitro coupled transcription and translation.
The membrane was incubated with 35S-Nup153 fragments corresponding to either (B) the
human full N-terminal domain (35S-hNup153N, residues 2-601), (C) the human N-terminal
fragment between residues 3-339 (35S-hNup153N339) or (D) the Xenopus C-terminal frag-




3.4.2 Nup153 interaction with the Ig-fold mutants of human lamin A
We next carried out solution binding assays to study the effect of the corresponding R453W
mutation in human lamin A and the ability to bind Nup153. We recombinantly expressed
N- and C- terminal fragments of human Nup153 fused to a GST motif in E.coli, and we
expressed human lamin A Ig-fold fragments by a coupled in vitro transcription/translation
system using rabbit reticulocyte lysate. Recombinant GST-Nup153 fusion proteins were
purified, immobilised on glutathione-sepharose beads and incubated with 35S-labelled
lamins. Bound and unbound protein fractions were analysed by SDS-PAGE and subjected
to autoradiography. As shown in Figure 3.2A, GST-fusions comprising an N-terminal frag-
ment of human Nup153 (residues 2-339; GST-N339), and the C-terminal domain of human
Nup153 (residues 874-1475; GST-hC) interact with the Ig-fold of wild-type lamin A (LA-
Ig). Consistent with our blot overlay data, we observed that the R453W mutant binds to
the N-terminal domain of Nup153, but weaker binding to the C-terminus (Figure 3.2B).
Similarly, when we mutated R482 to W, a mutation related to FPLD (Hegele et al., 2000),
the binding of the C-terminal domain of Nup153 was weaker as compared to wild-type
LA the AD-EDMD mutant, whereas the association with the N-terminal domain was not
affected by this mutation (Figure 3.2C). No banding of either wild-type or mutant Ig-fold
fragments to GST alone was observed. Together these data support that binding of the
N-terminal and C-terminal domain of to lamins involves distinct residues in the Ig-fold.
3.4.3 The N-terminal sub-fragments of Nup153 between residues 3-339 re-
veal specific interaction with the mutant containing Ig-fold
We next aimed to more precisely analyse which residues in the N-terminal domain of
Nup153 are implicated in the interaction with the Ig-fold of human LA and subsequent
effect of the Ig-fold mutants on binding. To do so, we employed sub-fragments of the N-
terminal domain of human Nup153 fused to GST comprising residues 2-144, 39-110, 39-
144, 87-144, 145-339, and 39-339, respectively. These were immobilised on glutathione
sepharose, and incubated with the Ig-fold of lamin A mutants produced by coupled in
vitro transcription/translation using rabbit reticulocyte lysate. Unbound (U) and bound
(B) fractions were resolved by SDS-PAGE and subjected to autoradiography. As shown in
Figure 3.3B, the wild-type LA Ig-fold binds strongly to Nup153 fragments 39-339, 39-144,
87-144, 145-339 and weaker to residues 2-144 and 39-110. The R453W mutant binds
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Figure 3.2: Nup153 binds to the Ig-fold mutants of lamin A - (A) Solution-binding assays
were performed using recombinant GST-Nup153 fragments comprising a fragment of the N-
terminal domain of human Nup153 (residues 2-339; GST-N339) and the C-terminal domain of
human Nup153 (residues 874-1475; GST-hC). The Ig-fold of lamin A; (A) wild-type (LA-Ig),
(B) the AD-EDMD mutant, (C) R453W (LA-IgR453W) and the FPLD mutant, R482W (LA-
IgR482W) were labelled with 35S-methionine. GST-Nup153 fragments were immobilised on
glutathione-sepharose beads, incubated in solution with 35S-lamin fragments and unbound
(U) and bound (B) fractions were resolved by SDS-PAGE and autoradiography.
strongly to 39-144 and shows weaker interaction to all other N-terminal truncations of
Nup153 (Figure 3.3B). In contrast, the R482W mutant exhibits strong binding to residues
39-339, 87-144, 145-339, but only weak binding to 2-144, 38-110 and 39-144 (Figure
3.3C). A mutation in the tail domain downstream of the Ig-fold (LA∆50) does not affect
binding of the Nup153 fragments to lamin A (Figure 3.3D). Together these data indicate
that the Ig-fold of LA exhibits multiple binding sites for the N-terminal domain of Nup153,
with residues 39-87 being critical for binding to R453 and residues 2-39 for interaction
with R482.
3.4.4 Expression of distinct GFP-lamin A constructs in HeLa cells
After our biochemical characterisation of the interaction between Nup153 and lamin A, we
aimed to study the interplay between Nup153 and nuclear lamins in a cellular contex. To
do so, we performed transient transfections in HeLa cells. We expressed, GFP-lamin A, GFP-
lamin A R453W, GFP-lamin A R482W and GFP-lamin A∆50 in HeLa cells and cells were
fixed and stained with appropriate antibodies 24-48 hour post transfection. As shown in
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Figure 3.3: FPLD mutant in the Ig-fold destroys the binding site with Nup153 - Solu-
tion binding assays were carried out using recombinant GST-Nup153 sub-fragments of the N-
terminal domain within residues 2-339, i.e. GST-N (2-144), GST-N (39-110), GST-N (39-144),
GST-N (87-144), GST-N (145-339), GST-N (39-339) and GST alone. GST-Nup153 fragments
were immobilised on glutathione-sepharose beads and incubated with fragments comprising
the Ig-fold of lamin A; (A) wild-type (LA-Ig), (B) AD-EDMD mutant (LA-IgR453W), (C) FPLD
mutant (LA-IgR482W) and (D) the HGPS causing mutant (LA∆50, progerin) labelled with
35S-methionine. Unbound (U) and bound (B) fractions were eluted by the addition of sample
buffer and resolved by SDS-PAGE and autoradiography.
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Figure 3.4A, expression of GFP-LA did not alter Nup153 localisation at nuclear pore com-
plex and also lamin B1 localisation remained unchanged as compared to untransfected
cells. Similarly, expression of GFP-LAR453W in HeLa cells led to the formation of intranu-
clear aggregates and nuclear lobulation (Figure 3.4C). While Nup153 did not co-localise
with the aggregates of GFP-LAR482W, it was absent from nuclear blebs. Similarly, other FG-
repeat nucleoporins as detected by the antibody mAb414, lamin B2 as well as endogenous
LA did not co-localise with the R482W aggregates, although more lamin A was detected in
the nucleoplasm. Together these data indicate that mutations in the Ig-fold of lamin A did
not extensively alter the localisation of Nup153 in the context of HeLa cells.
3.4.5 Expression of lamin A∆50 in HeLa cells disrupts the localisation of
Nup153
We next expressed GFP-lamin A∆50 in HeLa cells and as shown in Figure 3.4D, 24 h
post transfection cells expressing lamin A∆50 have misshapen nuclei and show speckle
like nucleoplasmic aggregates of lamin A. Nup153 staining is partially co-localising with
some of these aggregates and is absent from nuclear blebs (Figure 3.4D). In addition 48
hour post transfection, Nup153 staining is mislocalised and endogenous lamin A staining is
missing in cells expressing lamin A∆50. FG-nucleoporins detected by mAb414 and lamin
B1 localisation were not affected in transfected cells. Our data indicate that the localisation
of Nup153 is particularly altered in the presence of lamin A∆50 mutant in HeLa cells.
3.4.6 HeLa cells expressing lamin B variants show overlapping regions with
Nup153
Next we studied the effect of altered B-type lamin expression on Nup153 localisation in
HeLa cells. We expressed wild-type human lamin B1 and lamin B2 fused to GFP and YFP,
respectively, or Xenopus LIII in HeLa cells and cells were fixed and stained with appropriate
antibodies 24-48 hour post transfection. As illustrated in Figure 3.5A, cells overexpressing
any B-type lamin have misshapen nuclei including aggregation and nuclear blebbing of
lamin B. Nup153 co-aggregates with lamin B and is also recruited in nuclear blebs (Figure
3.5A). Moreover, Nup153 is absent from the nuclear rim in cells overexpressing lamin
B2. Staining with the mAb414, revealed that other FG-nucleoporins partially co-localise
with lamin B1 aggregates (Figure 3.5A). Next, we introduced a mutation in the lamin B1
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Figure 3.4: Nuclear Nup153 localisation in cells expressing GFP-lamin A with Ig-fold
and tail domain mutant - Confocal images of HeLa nuclei transiently expressing wild-type
GFP-human lamin A and mutations (green). (A) GFP-lamin A wild-type, (B) GFP-lamin A
with R453W mutation (GFP-R453W), (C) GFP-lamin A with R482W (GFP-R482W), and (D)
GFP-lamin A with a deletion of 50 residues at the C-terminal domain (GFP-LA∆50). 24-48
post transfection, cells were fixed and co-stained with appropriate antibodies against Nup153,
mAb414 (red), lamin A (LA), B1 (LB1) and B2 (LB2) (magenta). Scale bar, 20 µm.
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CAAX-box motif (i.e. CAIM) by substituting the cysteine (C) by a serine (S). This mutation
prevents the lipid modification of lamin B1 and its incorporation into the nuclear lamina
as well as lamin B1 accumulation into intranuclear aggregates in cells transfected with this
mutation (Mical and Monteiro, 1998). We transiently expressed GFP-LB1 construct with
this mutation (GFP-LB1 SAIM) in HeLa cells and examined the influence of this mutant
on the localisation of Nup153, mAb414 and lamins. Figure 3.5B shows that expression
of the CAAX-box mutant causes nuclear abnormalities and butterfly- shaped nuclei, lamin
B1 aggregation in the nucleoplasm and its absence from the nuclear rim. Nup153 and
mAb414 exhibit minor co-localisation with lamin B1-SAIM aggregates and showed largely
normal rim staining in these cells 24 h and 48 h post transfection. Endogenous lamin B1
co-localises with the lamin B1-SAIM aggregates. These data indicate that Nup153 binding
to lamin B1 requires an intact CAAX-box motif.
3.4.7 Lamins are not recruited to nuclear foci in HeLa overexpressing human
Nup153
We have previously shown that overexpression of GFP-Nup153 in HeLa cells leads to its
accumulation in intranuclear foci (Lussi et al., submitted). Hence, we next transiently
overexpressed Nup153 in HeLa cells and examined for the presence of nuclear lamins in
Nup153 aggregates. Figure 3.6 shows that Nup153 when overexpressed accumulates in
foci in nucleoplasmic aggregates, however, these aggregates do not contain lamin A or
lamin B1. Moreover, some nuclei expressing GFP-Nup153 show slight nuclear blebbing
and lamin B1 is not recruited to these nuclear blebs (Figure 3.6). These data indicate that
Nup153 only associates with membrane-bound nuclear lamins and that soluble Nup153
does not disrupt an intact nuclear lamina.
3.4.8 A- and B-type lamins fused to GFP do not bind equally to Nup153 in
HeLa cells
Finally, we examined whether Nup153 and lamins over-expressed in HeLa cells can be
co-immunoprecipitated from cell extracts. Cells were first transfected with GFP-lamin A
constructs, with wild-type GFP-LA as well as R453W, R482W and LA∆50 constructs, re-
spectively. 24-48 hr post transfection, cells were harvested and lysed. A monoclonal an-
tibody against GFP was used to precipitate the GFP-LA fusion proteins. The immunopre-
cipitates were analysed for the presence of Nup153 by immunoblotting and it was found
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Figure 3.5: Nup153 co-aggregates with GFP-lamin B variants - (A) Confocal images of
HeLa cells transiently expressing GFP-human lamin B and Xenopus LIII constructs (green). (A)
GFP-human lamin B1 (GFP LB1), YFP-human lamin B2 (YFP LB2, yellow), or GFP-Xenopus LIII
(GFP LIII). (B) GFP-lamin B1 with an amino acid substitution in the CAAX box domain, SAIM
(GFP LB1 SAIM). 24-48 h post transfection, cells were fixed and co-stained with appropriate
antibodies against Nup153, mAb414 (red), lamin A (LA), B1 (LB1) and B2 (LB2) (magenta).
Scale bar, 20 µm.
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Figure 3.6: Distribution of A- and B-type lamins in HeLa nuclei overexpressing Nup153
- HeLa cells transfected with GFP-human Nup153 (GFP-Nup153) (green) were fixed 24-48 h
post transfection and were co-stained with antibodies against lamin A (LA), lamin B1 (LB1) or
mAb414 (red). Scale bar: top left, 10 µm; middle left, 20 µm.
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that Nup153 co-precipitated with GFP-LA, GFP-LA(R453W) and GFP-LA(R482W), but not
with GFP-LA∆50 (Figure 3.7). When GFP-lamin B1, lamin B1-SAIM, lamin B2 and LIII
were expressed in HeLa cells and immunoprecipitated, neither amounts were found to
co-precipitate Nup153, consistent with previous data (Al-Haboubi et al., submitted).
Figure 3.7: Co-immunoprecipitation of Nup153 from HeLa transfected with lamins -
(A) Wild-type GFP-lamin A (GFP-LA) and mutants; R453W (GFP-LA(R453W)), R482W (GFP-
LA(R482W)), and lamin A∆50 (GFP-LA∆50), overexpressed in HeLa were immunoprecipi-
tated using anti-GFP antibodies. Equivalent amounts of HeLa extracts (L), immune super-
natants (S) and immune precipitate (P) were separated by SDS-PAGE and analysed by im-
munoblotting using anti-Nup153 that recognise the C-terminal domain (SA1; Nup153), anti-
lamin A (LA) and anti-GFP antibodies, respectively. (B) Immunoblots of GFP fused fragments
containing human; lamin B1 (GFP-LB1), B1-SAIM (GFP-LB1-SAIM), B2 (GFP-LB2) and the
Xenopus LIII (GFP-LIII) overexpressed in HeLa and analysed by immunoblotting using anti-
Nup153 and anti-GFP antibodies, respectively.
3.5 Discussion
Our recent data showed that Nup153 interacts with lamin A and lamin B both in vitro from
solution binding assays and from immunoprecipitates of HeLa cell extracts. Mutually the
N-and the C-terminal domains of Nup153 were found to bind specifically to the Ig-fold
domain of the lamins. In addition we mapped the interaction at a specific site in the NPAR
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of the N-terminal domain of Nup153 between residues 39-339 to be involved in binding
to the Ig-fold of lamin A. Our findings led us to predict a role for Nup153 binding to lamin
A which could be relevant in lamin disease related mutations. Here we examined this in-
teraction in the presence of three mutations in lamin A. Our binding assays reveal that the
strength of interaction between Nup153 and the Ig-fold is altered in the presence of Ig-fold
related mutations R453W and R482W, respectively, nut not disrupted (see Figure 3.1, 3.2B
and 3.2C). Nevertheless, our data document that Nup153 binding to lamins is perturbed in
the presence of mutations in the Ig-fold. We show that overall both mutants of the Ig-fold
R453W and R482W do not lose their tendency to bind to the fragments comprising the
residues 2-339 and the C-terminal fragments of Nup153 in vitro (Figure 3.2B and 3.2C).
However, it became more obvious when sub-fragment of the N-terminal binding domain of
Nup153 were analysed for binding specificity that the FPLD mutant R482W interfered dra-
matically with the Ig-fold binding strength with Nup153. Very weak to no binding is promi-
nent when Nup153 fragment comprising residues 39-144 was tested (Figure 3.3C). This
is the binding site that presented a strong binding with the Ig-fold of wild-type lamin A,
which is in agreement with our recent binding data (Al-Haboubi et al., submitted). This im-
plicates that the binding site influenced by the R482W mutation is critical for binding with
Nup153. While the R453W mutation that was shown to affect the overall lamin molecule
structure (Krimm et al., 2002) retained some binding with Nup153 from our solution bind-
ing assays. In addition, our data show that a deletion of 50 residues in the tail domain of
lamin A causing HPGS (LA∆50) did not disrupt the binding between lamin A and Nup153
in vitro (Figure 3.3D). Moreover, LA∆50 binding with Nup153 demonstrated a similar pat-
tern seen with Ig-fold of wild-type lamin A when distinct Nup153 sub-fragments of the
N-terminal binding domain were examined for binding, i.e. strong binding within residues
39-144 and 39-339, respectively. We further analysed the interaction between lamin A
and Nup153 in vivo using HeLa cells transiently expressing lamin A mutants. Clearly, cells
expressing AD-EDMD (R453W) and FPLD (482) mutations show accumulation of lamin
A into intranuclear foci (see Figure 3.4B and 3.4C). Cells transiently expressing R453W
show some lamin A aggregates with minor re-distribution of Nup153 in mutated cells (Fig-
ure 3.4B), whereas cells expressing R482W showed an increase of nuclear aggregates and
some blebbing to which Nup153 is not recruited. Furthermore, cells transiently expressing
lamin A∆50 displayed misshapen nuclei with nuclear blebs and some lobulation (Figure
3.4D). Staining of Nup153 in these nuclei was either very faint to no rim staining as well as
69
3.5 Discussion
some gaps or hole-like regions in Nup153 localisation (Figure 3.4D). Our cell based stud-
ies showed that Nup153 is mislocalised in cells overexpressing the HGPS causing mutant,
lamin A∆50 which is supported by earlier finding where Nup153 was mislocalised and
co-aggregated with lamin A in the presence of lamin A mutation (Goldman et al., 2004;
Hubner et al., 2006b), although both proteins still interact in vitro (see Figure 3.3D).
Furthermore, R482W immunoprecipitated a lesser amount of Nup153 than R453W or
wild-type lamin A which suggest a stronger binding of Nup153 with the Ig-fold at that
particular site (i.e. residue 482). Our immunoprecipitation assays revealed binding of
Nup153 to lamin A∆50, again in contrast to our in vitro studies (Figure 3.3D).
When analysing the interaction between Nup153 and B-type lamins, co-localisation of
Nup153 with lamin B in cells transiently expressing human lamin B1, B2 and the Xenopus
LIII was found (Figure 3.5A). In particular, Nup153 is present in nuclear blebs seen in
cells overexpressing lamin B1 (Figure 3.5A). We then questioned whether removal of the
membrane tethering domain of lamin B could influence its nuclear lamina localisation
and further re-distribute Nup153 into intanuclear foci. Cells expressing lamin B1 with a
mutation at the CAAX-box motif (lamin B1-SAIM) show huge intranuclear foci but Nup153
is not associated with these aggregates (Figure 3.5B). We also did not detect Nup153 in
lamin B1-SAIM immunoprecipitates, and our data show no Nup153 detected in the bound
as well as when GFP lamin B1 wild-type and lamin B2. Our data presented here show that
the association of the Ig-fold of lamin A with Nup153 is perturbed in the presence of two
missense mutations in the Ig-fold. A mutation responsible for AD-EDMD showed weaker
binding but overall the interaction is preserved. Whereas a mutation causing FPLD showed
loss of binding with Nup153 both in vitro and in cells expressing the mutation, indicating
the importance of this site for binding to Nup153. The interaction of Nup153 with lamin
A is unaffected in the presence of LA∆50 in vitro further supporting a direct interaction of
Nup153 with nuclear lamins to be with the Ig-fold. Our data implicate the importance of
a mutation in the Ig-fold that is responsible for FPLD as a mutation at this site interferes
dramatically with binding to Nup153 and to a lesser extent a mutation causing AD-EDMD.
The exact influence of Nup153 on the disease severity and phenotype connected with lamin
A mutations upon binding to lamins is yet to be defined.
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LIII is the major B-type lamin of the Xenopus oocytes, which was previously demonstrated
to form 10 nm IF-like filament structures in extracted nuclear envelopes. In vitro, LIII was
shown to form paracrystal like assemblies, however, defining earlier steps of ultrastructures
from LIII self-assembly are not yet determined. Here, we characterised assembly condi-
tions of LIII in vitro. We first expressed and purified recombinant LIII in E. coli, followed by
ultra-structural studies of LIII assembly pattern by electron microscopy (EM) using glycerol
spraying/low-angle rotary metal shadowing and negative staining. LIII samples were dial-
ysed against different assembly buffer conditions to study the effect of varied pH and ionic
strength on lamin assembly. Our EM of glycerol sprayed/rotary metal shadowed samples
show that at high salt (300 mM NaCl), high pH (8.6), LIII forms dimers. These dimers
comprise a long tail measuring ∼52 nm and two globular heads at one end. The tail rep-
resents two lamin α-helical coiled-coil rod domains and the globular head represents the
C-terminal domain, predominantly the globular Ig-fold structure. Furthermore, LIII dimers
associate longitudinally into polar head-to-tail polymers at 300 mM NaCl, pH 6.5, which
tend to associate laterally in a partially staggered fashion, when the NaCl concentration is
lowered to 100 mM. In addition, LIII dimers form paracrystal-like structures with ∼24 nm
axial repeats at pH 6.5 in the absence of CaCl2. More tightly packed paracrystal repeats
were seen when CaCl2 was added at pH 8.6 revealing axial repeats of ∼17 nm length.
Moreover, we reveal that LIII head-to-tail polymers are disrupted in the presence of Nudel,
an LIII-interacting protein, which may play a role in recruiting LIII to microtubules, and
subsequently in spindle matrix specific LIII assembly.
4.2 Introduction
The nuclear lamina is a filamentous meshwork comprising mainly the nuclear lamins as
well as lamin-associated polypeptides at the nuclear periphery of all metazoan cells. Nu-
clear lamins are type V intermediate filament proteins (IFs) and like all IFs, lamins have
a tripartite domain organisation, comprising a central α-helical coiled-coil rod domain
flanked by two non-helical short N- terminal (head) domain and a longer C- terminal (tail)
domain (Parry et al., 1987). The long rod domain consists of four coiled-coil heptad repeat
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segments; 1A, 1B, 2A and 2B separated by three non-helical linkers; L1, L12 and L2, re-
spectively (Heins and Aebi, 1994). The N- and C-terminal end segments of the rod domain
are highly conserved among all IFs and influence lamin assembly into higher order struc-
tures (Fraser and MacRae, 1985; Stuurman et al., 1998). Additionally, the rod domain of
lamins contains an extra six heptad repeats (42 residues) in segment 1B, which are shared
by the rod domain of invertebrate IFs, but not present in the cytoplamsic IFs (Herrmann
and Aebi, 2004; Weber et al., 1989). The tail domain is characterised by distinct domains
that are found only in lamins but not in cytoplasmic IFs: i) a nuclear localisation signal
(NLS), ii) an immunoglobulin-like motif (Ig-fold) domain and iii) a -CAAX box domain
that undergoes multiple posttranslational modifications (Kitten and Nigg, 1991; Monteiro
et al., 1994; Ralle et al., 2004). Lamins have multiple phophorylation sites located at the
rod domain, which have several roles in the assembly and disassembly of lamins from the
lamina during NE breakdown at the onset of mitosis (Heald and McKeon, 1990; Moir et al.,
1995; Nigg, 1992; Peter et al., 1991). Lamins are divided into two major types, A- and B-
type lamins, which can be distinguished by their expression pattern, amino acid sequence
and biochemical properties. A-type lamins are splicing products encoded by a single gene,
LMNA which give rise to lamin A and lamin C in somatic cells, as well as lamin A∆10
and lamin C2 in germ-line specific cells, respectively (Alsheimer and Benavente, 1996;
Furukawa et al., 1994). A-type lamins are only found in differentiated cells, they have a
neutral iso-electric point, and are soluble during mitosis (Fisher et al., 1986; Furukawa et
al., 1994; Gerace and Burke, 1988). B-type lamins are encoded by two separate genes,
LMNB1 and LMNB2, giving rise to lamin B1 and B2 in somatic cells as well as lamin B3
and B4 in sperm cells, respectively (Furukawa and Hotta, 1993; Lin and Worman, 1995;
Lourim et al., 1996; Vorburger et al., 1989). B-type lamins are present in all cell types,
have an acidic isoelectric point and remain membrane-bound during mitosis (Georgatos et
al., 1994). Nuclear lamins of the Xenopus oocytes form 10 nm diameter IF-like filaments,
which are organised in a lattice meshwork of near tetragonally oriented filaments (Aebi
et al., 1986). The Xenopus oocytes contain one major unique B-type lamin termed LIII
or LB3 sharing a closer sequence homology with lamin A and primary sequence similar-
ities with invertebrate IF genes as well (Doring and Stick, 1990; Stick, 1988; Stuurman
et al., 1998). Two isoforms are found in Xenopus oocytes, which differ by 12 residues at
the C-terminal domain in their CAAX-encoding exons. LIIIb is a minor variant that carries
an extra cysteine and a cluster of six basic residues in proximity of the CAAX-box domain
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(Doring and Stick, 1990). Other lamins in the Xenopus include three somatic lamins LI, LII
and LA equivalent to the mammalian lamin B1, B2 and A, respectively as well as a minor
germ-line specific lamin LIV (Benavente et al., 1985; Stick and Hausen, 1985). Charac-
terisation of the self-assembly properties of lamins have been extensively studied in vitro
using transmission electron microscopy (EM) using recombinant lamin expressed in bacte-
ria. In vitro, lamin assembly begins with lamin monomers association in their rod domain
in a parallel unstaggered fashion giving rise to two-stranded α-helical coiled-coil dimers,
measuring ∼50 nm long in the rod domain and flanked by two globular heads at the C-
terminal domain (Heitlinger et al., 1991; Heitlinger et al., 1992). Lamin dimers elongate
longitudinally head-to-tail forming ∼2 nm wide head-to-tail polymers with an axial repeat
of 48-50 nm, thus differing from cytoplasmic IFs that form lateral association into anti-
parallel unstaggered or half staggered tetramers (Heins and Aebi, 1994; Heitlinger et al.,
1991). Eventually, lamins form filamentous bundles and paracrystalline arrays, assemblies
that overextend laterally with a diameter of more than 13 nm and 24-25 nm axial re-
peats (Heitlinger et al., 1991; Stuurman et al., 1998). Unlike cytoplasmic IFs which form
filaments in vitro, only C.elegans lamin B has been form filaments in vitro that are com-
posed of 3 and 4 tetrameric protofilaments, each of which contains two partially staggered
anti-parallel head-to-tail polymers (Ben-Harush et al., 2009; Karabinos et al., 2003). In
addition, the tunicate C. intestinalis lamin also assembles into filaments, but with a smaller
average diameter of 5.4 nm (Karabinos et al., 2003). Paracrystal- like structures are also
seen when Xenopus lamin A or Drosophila lamin C are expressed in insect cells, whereas
Xenopus LI and Drosophila Dm0, a B-type lamin, assemble into filamentous fibrous in insect
cells (Klapper et al., 1997). In addition, mutations studies have show that the head and
tail domains of lamins play major roles in the assembly steps of the polypeptides. Headless
chicken lamin A and lamin B2 do not form head-to-tail assemblies, whereas a tailless mu-
tant forms long filaments and enhanced paracrystalline fibers assembly with normal axial
repeats (Heitlinger et al., 1992). Tailless lamin Xenopus lamin A, C. elegans lamin B, or
the Drosophila lamin Dm0, on the other hand, form filament bundles lacking the 24-nm
axial repeats seen in normal paracrystals, and tailless human lamin C forms 15-30 nm fila-
ments instead of paracrystals (Ben-Harush et al., 2009; Gieffers and Krohne, 1991; Izumi
et al., 2000; Moir et al., 1991; Sasse et al., 1998). These studies demonstrated that these
mutations have a dominant negative effect when expressed in mammalian cells, leading
to aggregation of the endogenously expressed lamin isoforms (Izumi et al., 2000; Moir et
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al., 2000; Spann et al., 1997). Other studies have shown that the Ig-fold motif as well
as the tail domain of the Xenopus LIII is sufficient to inhibit lamin polymerisation in vitro
and nuclear assembly in Xenopus egg extracts (Lopez-Soler et al., 2001; Shumaker et al.,
2005). More recently, it was shown that LIII polymerisation in vitro into paracrystals is
prevented by importin-α (Adam et al., 2008). Here, we have established buffer conditions
required for distinct assembly steps of recombinant LIII in vitro. Furthermore, we show
that Nudel, a recently identified LIII-binding protein (Ma et al., 2009), which is predicted
to induce filamentous structures of LIII, disrupts LIII head-to-tail associations.
4.3 Experimental Procedures
All experimental procedures were carried out at room temperature, unless otherwise stated.
4.3.1 Bacterial expression and purification of LIII
Xenopus LIII in pET vector was a generous gift of Prof. R.D. Goldman. pET-LIII was ex-
pressed in E.coli BL21-DE3 codon (+) strain. 10 ml overnight culture was diluted into
1 litre of LB-medium with appropriate antibiotics and grown at 37 ◦C until an OD600 of
0.6 was reached. LIII expression was then induced by the addition of 0.4 mM IPTG and
cells were grown in culture for 3 hours at 37 ◦C and shaking at 180 rpm. Bacterial pel-
lets were collected by centrifugation at 5000 rpm for 15 min at 4 ◦C (SLA3000, Sorvall).
The pellet was resuspended in 10 ml of lysis buffer containing 50 mM Tris-HCl pH 8.0,
25% sucrose, 1mM EDTA, 1mM PMSF, 1mM leupeptin, 1mM aprotinin, and 1mM DTT on
ice. The pellet was then homogenised by 10 sec sonication bursts and 20 ml of detergent
buffer containing 25 mM Tris-HCl pH 8.0, 200 mM NaCl, 1% NP-40, 1% deoxycholate,
1mM EDTA, 1mM PMSF, 1mM leupeptin, 1mM aprotinin, and 1mM DTT was added to the
resuspended bacterial cells on ice and was then homogenised using a sonicator. Lysed cells
were then pelleted by centrifugation at 9000 g for 45 min at 4 ◦C. Insoluble lamin pellet
was then washed 3 times by resuspending in wash buffer containing 25 mM Tris-HCl pH
8.0, 200 mM NaCl, 0.5% NP-40, 1mM EDTA, 1mM PMSF, 1mM leupeptin, 1mM aprotinin,
and 1mM DTT on ice, and centrifugation at 9000 g for 15 min at 4 ◦C. Inclusion bodies
were then dissolved in 8 ml of column buffer containing 10 mM Tris-HCl pH 8.0, 8 M urea,
2 mM EDTA, 1mM PMSF, 1mM leupeptin, 1mM aprotinin, 10 mM DTT, using a Dounce
homogeniser and centrifuged at 200,000 g for 45 min at room temperature.
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4.3.2 LIII protein purification
Solubilised inclusion bodies were loaded onto 3 ml of Q-sepharose pre-equilibrated col-
umn, which was eluted with a linear 0-600 mM NaCl gradient in column buffer. Eluted
fractions were separated by SDS-PAGE and desired fractions were undergone a second
step of purification onto a Superdex 200 FPLC size exclusion chromatography column (GE
healthcare- Amersham Biosciences, Uppsala, Sweden) following manufacture’s protocol.
LIII fractions were collected in 10 mM Tris-HCl pH 8.6, 8 M urea, 300 mM NaCl2, 1mM
leupeptin, 1mM aprotinin, 10 mM DTT. Aliquots were stored at -80 ◦C.
4.3.3 SDS-PAGE and immunoblotting
Protein samples were resolved by SDS-PAGE and either stained with Coomassie blue or
transferred to PVDF membrane and probed with the appropriate antibodies and developed
using the Western Lighting CDP-Star® Chemiluminescence Reagent (Tropix, Bedford MA,
USA) and Fuji Super RX-film (FujiFilm Corporation, Tokyo, Japan).
4.3.4 Recombinant Nudel protein
Recombinant NudeI protein fused to with His-tag was kindly supplied by Dr Y Zheng
(Carnegie Institution of Washington, Department of Embryology, Baltimore).
4.3.5 Sample preparation for electron microscopy
For glycerol spraying/low-angle rotary metal shadowing, 20 µl lamin sample was mixed
with glycerol to a final concentration of 30% and ∼10 µl was sprayed onto freshly cleaved
mica which was then mounted face up onto a rotary table of a Balzers apparatus (BAE
120T; Balzers Pfeiffer GmbH, Asslar, Germany) and dried at room temperature in vacuo.
Dried samples were rotary shadowed with platinum/carbon at an elevation angle of 3.5 ◦
and coated with a carbon film apparatus for metal evaporation, followed by rotary shadow-
ing with platinum/carbon at an angle of 3-5 ◦ as described previously (Aebi and Baschong,
2006; Fowler and Aebi, 1983). For negative staining, a sample aliquot of 5 µl was ad-
sorbed for 1 min to a glow-discharged carbon-coated collodion film on a copper grid (Aebi
and Pollard, 1987). Excess sample was drained with filter paper and grid was washed on
two drops of Milli-Q water, mounted with 1-2 µl of 2% uranyl acetate for 1 min and excess
liquid was drained with filter paper and the grid was air-dried. Samples were examined
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in either a Hitachi H-7000 transmission electron microscope (Hitachi, Japan) operated at
voltage 100 kV or Philips CM-100 transmission electron microscope (Philips, Eindhoven,
The Netherlands) operated at 100 kV. Electron micrographs were recorded on Kodak SO-
163 electron image film at a magnification of 50 000x. EM negative films were scanned
using PrimeScan D7100 Drum scanner (PrimScan, Heidelberg) and were further analysed
using Adoobe Photoshop CS4.
4.4 Results
4.4.1 Bacterial expression and purification of recombinant LIII
Xenopus LIII in a pET vector was first expressed in E.coli DE3 codon (+) cells in inclusion
bodies, followed by two steps of purifications of the solubilised LIII in 8 M urea containing
buffer. LIII was loaded onto a Q-anion exchange chromatography column, which resulted
in partial purification of LIII. These partially purified LIII fractions were next loaded onto
a Superdex 200 size exclusion chromatography column and fully purified protein fractions
were resolved by SDS-PAGE as shown in Figure 4.1A. The identification of the 67-kDa pro-
teins was further verified by immunoblotting with LIII specific antibody 299 (a kind gift of
Prof R.D. Goldman), as well as by mass spectrometry (Dr Paul Jenö, Mass spectrometry,
Biozentrum, University of Basel). Protein concentrations were measured at λ595 to be ∼ 4
mg/ml, and protein aliquots in dimer buffer (10 mM Tris, 300 mM NaCl, 8 M urea, 5 mM
DTT, pH 8.6) were stored at -80 ◦C. For LIII assembly analysis, the protein was first rena-
tured stepwise by dialysing against dimer buffer with the decreasing urea concentrations
ranging from 8-0 M. A protein concentration of 0.2-0.4 mg/ml was measured for the fully
renatured protein and was resolved by SDS-PAGE as shown in Figure 4.1B. For in vitro
assembly studies a protein concentration of 0.2 mg/ml was used.
4.4.2 LIII dimer formation
LIII aliquots in 8 M urea containing dimer buffer were first renatured stepwise dialysis from
8, 6, 4, 2, 1, and 0 M urea containing 10 mM Tris-HCl pH 8.6, 300 mM NaCl, 2 mM DTT for
4 hours at room temperature. Figure 4.2C shows EM micrographs of glycerol sprayed/low-
angle rotary metal shadowed LIII dimers. These dimers are represented by a long tail with
a length of 51.9 ± 1.3 nm and two globular heads at one end, similarly to previously
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Figure 4.1: Purification of recombinant LIII - LIII was expressed in E.coli and purified by Q-
anion exchange chromatography followed by (A) size exclusion chromatography as described
in the experimental procedures. Collected fractions were resolved by SDS-PAGE. (B) Rena-
tured LIII following sequential dialysis in dimer buffer lowering urea concentration from 8, 6,
4, 2,1 and 0 M.
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documented ultrastructures seen in chicken lamin B2 and other lamins (Heitlinger et al.,
1991; Sasse et al., 1997). The tail represents two lamin molecules associating at the α-
helical coiled-coil of rod domain. The two globular head structures correspond to the
Ig-fold of the tail domain of LIII.
Figure 4.2: LIII dimers - 0.2 mg/ml recombinant LIII was dialysed stepwise against 8 M to
0 M urea in dimer buffer containing 10 mM Tris-HCl pH 8.6, 300 mM NaCl, 8 M urea, 5 mM
DTT and protease inhibitors for 4 hours. Dialysed LIII samples were glycerol sprayed/rotary
metal shadowed as described in the experimental procedures. LIII dimers have a long tail of
51.9 ± 1.3 nm representing the rod domain and two globular heads at one end representing
the Ig-fold of the tail domain. Scale bar, 100 nm and 50 nm in the insert.
4.4.3 "Head-to-tail" assemblies of LIII dimers in vitro
LIII samples renatured by stepwise dialysing into dimer buffer were then dialysed against
different buffer conditions with varying pH from 9-6 and salt concentration from 0.5-0 M
NaCl. Longitudinal polar head-to-tail polymer associations were observed when LIII dimers
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were dialysed against 25 mM MES pH 6.5, 300 mM NaCl, 1 mM DTT for 2-3 hours as
shown on EM micrographs of glycerol sprayed/low-angle rotary shadowed LIII assembled
head-to-tail polymers in Figure 4.3A. Maintaining the pH at 6.5 but lowering the salt con-
centration to 200 mM NaCl resulted in shorter head-to-tail association as shown in Figure
4.3B. However, in the presence of only 100 mM NaCl lateral association of half staggered
head-to-tail polymers were becoming more obvious as seen in Figure 4.3C.
4.4.4 Paracrystal assemblies of LIII
LIII samples were first renatured in dimer buffer and then dialysed against 25 mM MES
pH 6.5, 100 mM NaCl, 1 mM DTT for 2 hours, which resulted in some filament- like
structures when examined by negative staining (see Figure 4.4A). However, Figure 4.4B
shows an EM micrograph of negatively stained LIII dimers dialysed against 25 mM MES
pH 6.5, 1 mM DTT which induced paracrystal-like structures, revealing 24.7±1.3 nm axial
repeats. Furthemore, dialysing LIII dimers in other established conditions for paracrystal
formation resulted in more loosely packed paracrystals when dialysed against 25 mM MES
pH 6.5, 20 mM CaCl2 for 1-2 hours, as shown in Figure 4.4C. However, Figure 4.4D, shows
negatively stained LIII that the presence of 20 mM CaCl2 in more alkaline pH (8.6) led to
the formation of a tightly packed paracrystalline arrays with 17.2±1.4 nm axial repeats.
4.4.5 LIII head-to-tail assemblies are affected by the presence of Nudel
We next examined whether the addition of Nudel have an influence on the polymerisation
of LIII into higher order assemblies. LIII samples were pre-assembled into either dimers or
head-to-tail polymers, mixed 1:1 with Nudel full length and then dialysed against head-
to-tail buffer containing 25 mM MES pH 6.5, 300 mM NaCl, 1 mM DTT, 1 mM PMSF for
2-3 hours at room temperature. Figure 4.5 shows EM micrographs of glycerol sprayed/
rotary metal shadowed LIII in head-to-tail assembly condition in the presence of Nudel.
Nudel was added either to pre-assembled LIII dimer as represented in Figure 4.5A, or with
pre-polymerised head-to-tail assemblies in Figure 4.5B. The addition of Nudel disrupts the
tendency of LIII dimers to form polar head-to-tail association (Figure 4.5A; see also Fig-
ure 4.3A). In addition, when added to pre- assembled head-to-tail LIII, Nudel disrupted
these polymers as demonstrated by the absence of longitudinal polar head-to-tail associa-
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Figure 4.3: LIII dimers form head-to-tail polymers that extend laterally by lowering ionic
strength - EM of glycerol sprayed/low-angle rotary metal shadowed LIII samples. LIII samples
in 8 M urea were dialysed stepwise against dimer buffer (10 mM Tris-HCl pH 6.5, 300 mM
NaCl, 8 M urea, 5 mM DTT) for 4 hours and were then dialysed into low pH buffer of varying
salt concentration. (A) LIII dimers dialysed against 25 mM MES pH 6.5, 300 mM NaCl, 1 mM
DTT, 1 mM PMSF and protease inhibitors for 2-3 hours resulted into polar head-to-tail associ-
ations. (B) Lowering salt concentration to 200 mM NaCl resulted into head-to-tail aggregates.
(C) Lowering salt concentration even further to100 mM NaCl resulted in head-to-tail polymers
to associate laterally in a staggered fashion. Scale bar (A-C), 100 nm.
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Figure 4.4: LIII paracrystal assemblies - EM of negatively stained LIII higher order structures
formed in different buffer conditions. Renatured LIII dimer samples were dialysed for 2 hours
against (A) 25 mM MES pH 6.5, 100 mM NaCl, 1 mM DTT to form filament like structures.
Paracrystals were formed when dialysed against three different buffers: (B) 25 mM MES pH
6.5, 1 mM DTT. (C) 25 mM MES pH 6.5, 20 mM CaCl2, 1 mM DTT and (D) 10 mM Tris-HCl
pH 8.5, 20 mM CaCl2, 1 mM DTT. Scale bar, 100 nm.
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tions seen in Figure 4.5B and resulted in protein aggregation when examined by negative
staining (data not shown).
Figure 4.5: Nudel interferes with LIII assembly into head-to-tail polymers - LIII samples
dialysed in dimer buffer as described in Section 4.3 were (A) pre-assembled onto head-to-tail
polymers by dialysing in 25 mM MES, 300 mM NaCl, 1 mM DTT, 1 mM PMSF, pH 6.5 for
3 hours and then were mixed 1:1 with Nudel and incubated for another 2-3 hours at room
temperature. (B) LIII dimers were first mixed with Nudel and then dialysed against head-to-
tail buffer condition. Samples were then subjected to glycerol spraying/low-angle rotary metal




Xenopus LIII is the major B-type lamin found in the oocytes and its structural assembly
of 10 nm IF-like filaments meshwork at the nuclear envelope was one of the earliest doc-
umented (Aebi et al., 1986). However, following the assembly of LIII in vitro was not
determined yet. Here we sought to examine the ultrastructural assembly pattern of LIII
in vitro. We expressed recombinant untagged LIII in E.coli to avoid any tag related influ-
ence on the biology of the expressed protein and assembly. LIII accumulated in inclusion
bodies and therefore was first solubilised in urea. The resulting denatured protein was
purified by anion exchange and size exclusion chromatography. Upon LIII renaturation in
dimer buffer containing 300 mM NaCl, pH 8.6, LIII molecules formed dimer-like structures
with a tail measuring 51.9 ± 1.3 nm in length and two globular heads at one end. The
long tail represents two α-helical coiled-coil that result from the association of two lamin
molecules at their rod domain and the globular heads represent the C-terminal domain
with its globular Ig-fold domain (Aebi et al., 1986; Heitlinger et al., 1991). LIII dimers
associated longitudinally upon lowering pH conditions (pH 6.5, 300 mM NaCl), leading to
polar head-to-tail assemblies, similar to previous studies (Heitlinger et al., 1991). These
head-to-tail polymers tend to become less longitudinally associated when lowering the
ionic strength (200 mM NaCl, pH 6.5) resulting in shorter assemblies, which start to as-
sociate more laterally at an even lower salt condition (100 mM NaCl, pH 6.5) resulting in
a partially staggered association. Furthermore, LIII dimers formed paracrystal like struc-
tures, with striated repeats when dialysed in buffers that favour paracrystal formation
(Heitlinger et al., 1991). However, the packing of these paracrystal structures deduced
from LIII varied depending on the pH as well as the presence of CaCl2. LIII formed large
paracrystals with 24.7± 1.3 nm axial repeats in pH 6.5 and with no salt. However, when
LIII was dialysed in the addition of 20 mM CaCl2, pH 6.5, more loosely packed striated re-
peats were observed. Moreover, when 20 mM CaCl2 was added at pH 8.6, this resulted in
paracrystal which were more tightly packed than either of the other paracrystal conditions
with 17.2± 1.4 nm axial repeats. This is in agreement with previously published assembly
studies of chicken lamin B2, where it was suggested that the pH influences the strength
of lateral inter-subunit associations without affecting overall strength of the longitudinal
inter-subunit bond (Heitlinger et al., 1991). Furthermore, we examined the effect of Nudel
on LIII head-to-tail assemblies, which has recently been demonstrated to recruit and aid in
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the assembly of LIII at the mitotic spindle (Ma et al., 2009). The exact influence of Nudel
on LIII assembly is not established. It is known however that Nudel associates with the
cytoplasmic IF protein vimentin, and interacts directly with LIII and neurofilaments (NFs)
(Helfand et al., 2002; Ma et al., 2009; Nguyen et al., 2004). Interaction of Nudel with
NFs induces filament formation (Nguyen et al., 2004). Our data show that unlike NFs,
Nudel did not induce LIII polymerisation into filaments; to the contrary, it disrupted head-
to-tail associations of LIII and resulted in aggregations of the protein observed by negative
staining. The mixture of Nudel with LIII dimers prevented head-to-tail association and
further disrupted pre-assembled head-to-tail polymers and led to aggregation. Recently,
it was shown that Nudel interacts specifically with coil 2 of the LIII rod domain, which is
highly conserved between all IFs and involved in lamin assembly to higher order structures
(Herrmann et al., 2007; Ma et al., 2009; Stuurman et al., 1998). However, how Nudel in-
teraction with coil 2 interferes with the head-to-tail assemblies that involve the very ends
of the rod domain is not clear. We speculate that Nudel function in the recruitment of LIII
in mitosis is mediated by further dissolving the small pool of non-solubilised LIII nuclear
envelope remnants which were not solubilised prior to nuclear envelope breakdown and
eventually transform LIII into a mitotic state specific meshwork which possibly result in a
distinct assembly pattern different than the normally assembled LIII on the nuclear periph-
ery in interphase cells and which is yet to be defined. In summary we have established
buffer conditions required for the assembly of recombinant LIII from dimers to head-to-tail
and further lateral associations as well as paracrystal formation. Certainly looking at the
effects of mutations in the head and tail domains of LIII on the assembly as well as the in-
fluence of lamin-associated proteins on forming higher order filamentous meshwork seen
in the living cell is of future interest.
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Already in 1976, it was documented that the nuclear lamina interacts with NPCs (Dwyer
and Blobel, 1976), and in the following that proper assembly of the NPCs into the nuclear
envelope requires an intact nuclear lamina (Enarson et al., 2001; Enarson et al., 1998).
More specifically, it was shown that the nucleoporin Nup153 recruitment to the nuclear
envelope also requires association with the lamina possibly through binding with lamin B
(Smythe et al., 2000). Direct association with nuclear lamins was thought to occur through
the C-terminal domain of Nup153 interacting with lamin B, but not lamin A (Smythe et
al., 2000). However, the localisation of Nup153 was also shown to be altered in cells
expressing mutations in lamin A, although no direct binding of Nup153 and lamin A has
been reported (Bechert et al., 2003; Goldman et al., 2004; Hubner et al., 2006; Muchir et
al., 2003).
5.1 Nup153 presents multiple binding sits for nuclear lamins
In order to analyse the interaction between Nup153 and nuclear lamins more systemati-
cally we performed solution binding assays and co-immunoprecipitation experiments. Our
studies revealed that the interaction between Nup153 and nuclear lamins is more com-
plex than anticipated (Al-Haboubi et al., submitted). Nup153 exhibits multiple binding
sites not only to lamin B but also to lamin A (Figure 2.1). Both the N-terminal and the
C-terminal domains of Nup153 interact with both A- and B-type lamins. In addition, we
showed that the interaction of the C-terminal, FG-repeat domain is not part of a nuclear
import complex (Figure 2.3). The C-terminal FG-repeat domain of Nup153 appears to be
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an unfolded structure, which has multiple topology at the NPCs (Fahrenkrog et al., 2002),
suggesting that the C-terminal domain of Nup153 folds back onto an intermediate com-
plex between Nup153 and the respective lamin at the NE. However, Nup153 also exists in
multiple populations at the nuclear interior as well as within the NPC (Griffis et al., 2004),
which indicates distinct association with lamin A in the nucleoplasm. However, it remains
to be seen whether potential nucleoplasmic Nup153-lamin A complexes can be correlated
to distinct functions, e.g. a structural role at the periphery of the NE or in complex with
chromatin associated proteins in the nucleoplasm. We further revealed that Nup153 binds
particularly to the Ig-fold of lamins and that differing binding sites exist for lamin A and B,
supporting the notion of multiple functions of the distinct Nup153-lamin complexes. We
mapped the specific region in the N-terminal domain of Nup153 within residues 39-339
which are necessary for binding to lamin A and residues 2-339 critical for interaction with
lamin B (Figure 2.5). Our immunoprecipitation data revealed that Nup153 interact with
lamin A, as well as B-type lamins in HeLa cell extracts providing in vivo evidence that
further support our in vitro data.
5.2 Nup153 interaction with lamins in the presence of lamin
mutation
In order to assign potential roles to the different kinds of interactions between Nup153
and nuclear lamins, we examined these interactions in the presence of lamin-associated
mutations. We employed further in vitro binding assays, immunofluorescence microscopy
and co-immunoprecipitation assays. Our studies revealed that a mutation in the Ig-fold,
responsible for FPLD (i.e. R482W), which results in disrupting a specific binding site of
lamin A, interferes dramatically with Nup153 binding. More specifically, the R482W muta-
tion caused loss of binding with Nup153 (Figure 3.3 and 3.4) not only in vitro but also in
vivo, further indicating the importance of this site for binding to Nup153. Another muta-
tion within the Ig-fold domain that destabilises the 3D-architecture of the lamin molecule
(i.e. R453W), and results in AD-EDMD, also proved to affect binding between Nup153
and lamin A in vitro, however, to a lesser extent. In contrast, the interaction of Nup153
with lamin A remained unaffected by the presence of the LA∆50 mutation (responsible for
HGPS) in vitro, thus further supporting a direct interaction of Nup153 with nuclear lamins
to be with the Ig-fold, which is not affected by the LA∆50 mutation. A correlation between
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the position of laminopathy-causing mutations and their upstream effect on binding with
Nup153 is plausible, and may account more explicitly for the specific tissue damages ob-
served with the different laminopathies. We hypothesise that the multiple lamin binding
sites within Nup153 exhibit multiple functional roles in conjunction with other nuclear pro-
teins, depending on the specific Nup153 domain binding (i.e. N-terminal or C-terminal)
as a result of complex formation with lamins. Altered interaction between Nup153 and
laminopathy-causing mutants of the tail domain (Ig-fold) may influence the functionality
or viability of Nup153 (see Section 1.6) and consequently subsequent pathologies, de-
pending on the mutation in question. We propose several possible roles for Nup153 in
laminopathies. Nup153 may have a structural role in the architecture of the nucleus. Loss
of binding with lamins as a result of lamin associated mutations could interfere with sub-
nuclear localisation of Nup153 at the nuclear periphery and with subsequent functions of
Nup153 in NE assembly and disassembly. Active genes are anchored to the NPC and si-
lenced to lamins at the periphery, thus the disruption of the Nup153-lamin complex could
interfere with the chromatin organisation at the periphery. It is also plausible that Nup153-
lamin complexes exist in the nucleoplasm. Whether these could act as genomic insulators
blocking the action of enhancer elements or as genomic activators is yet to be determined.
Moreover, altered binding of Nup153 with lamin A may alter the level of expression of
Nup153, which in turn could lead to severe effects in cytokinesis and cell cycle exit as
seen previously (Mackay et al., 2009). Altered domain functionality can lead to aberrant
nuclear morphology seen in cells with reduced levels of Nup153 at a early stage of mito-
sis with multi-lobed nuclei, these where partially rescued in the addition of NPAR region,
which support an additional role for this region in cell cycle progression. Moreover, re-
cently it was shown that Nup153 mediated nuclear import is reduced in laminopathic cells
(expressing LA∆50 mutation) (Busch et al., 2009). Mislocalised Nup153 can impair nor-
mal trafficking of mRNA and proteins and possibly the transport of regulatory proteins
required for cell cycle progression. Nup153 may have a role in the pathology of the dis-
ease through gene regulation, e.g. regarding expression of adipocyte-specific genes or the
provision of binding sites at the nuclear periphery that protect the cells against apoptosis,
and changes in chromosomal positioning due to defects in the cell cycle (Kalverda et al.,
2008).
88
5.3 Lamin LIII assembly
5.3 Lamin LIII assembly
The Xenopus oocytes lamin LIII was shown to from 10 nm IF-like filaments that arrange
in a regular meshwork (Aebi et al., 1986). Previously, in vitro assembly studies of other
mammalian lamins were documented (Heitlinger et al., 1991; Klapper et al., 1997; Sasse
et al., 1997). However the conditions for in vitro reconstitution of lamin LIII have not yet
been extensively studied. We dialysed recombinantly expressed LIII in various buffer con-
ditions with differing pH and ionic strength and examined LIII ultrastructures by electron
microscopy (EM) using glycerol spraying/low-angle rotary metal shadowing and negative
staining. LIII dimers were found to exhibit a typical ∼52 nm long tail and two globular
heads at one end (Figure 4.2). These dimers associated longitudinally into polar head-
to-tail polymers at high NaCl concentration and low pH (Figure 4.3). Without NaCl, also
at low pH paracrystal-like structures with ∼24 nm axial repeats were observed. These
paracystal-like structures were also formed in the presence of CaCl2 at high or low pH.
However, more tightly packed paracrystals with axial repeats of ∼17 nm were seen when
CaCl2 was added at high pH (Figure 4.4). Establishing the conditions required for head-to-
tail assemblies was important for future examination of the influence of the presence of LIII
binding proteins on the subsequent assembly into higher order structures. We showed that
LIII head-to-tail polymers are disrupted in the presence of Nudel, a protein that interacts
with LIII (Ma et al., 2009), and which may play a role in recruiting LIII to the microtubules
and subsequently in the assembly of mitotic spindle LIII specific meshwork (Tsai et al.,
2006).
5.4 Future directions
Future work should address the roles of distinct lamin A mutations affecting Nup153 bind-
ing in relation to type and severity of the diseases associated with these mutations. For
example, future studies should be directed toward better understanding of the role of
Nup153 in cell cycle progression in cells expressing lamin A mutations. The use of stable
cell lines with disease-causing lamin A mutants would allow for monitoring of the levels of
Nup153 and study of the cell cycle progression by the use of live-imaging techniques. In ad-
dition, studies may include examination of the effects of up-regulation or down-regulation
of Nup153 in cells with disease causing lamin A mutations. In addition, fibroblast derived
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from LMNA null mice could be used to investigate the effect that the transiently expressed
or microinjected Ig-fold of lamin A may have on the localisation of Nup153 in these cells.
To continue the work on LIII assembly, future in vitro studies should be directed at
investigating the effects of mutations in the head and tail domains of LIII as well as the in-
fluence of LIII-associated proteins on the formation of higher order filamentous meshwork,
as seen in the living amphibian cells.
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